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I. INTRODUCTION
In the foreseeable future, it is likely that the familiar, paper-based
patient medical files, contained in thick folders and stored on long
shelves or in filing cabinets, will become a thing of the past. Both the
federal government and health care advocates are enthusiastically
promoting the adoption of health information technology (“HIT”) and
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electronic health records (“EHR”) systems1 as means to transform and
improve health care in the U.S.2
An editorial published in The New York Times in August 2007
noted that the World Health Organization, in 2000, ranked the U.S.
health care system 37th out of 191 and identified our poor use of information technology as among the primary reasons for this “dismal”
ranking.3 The editorial decried the fact that “American primary care
doctors lag years behind doctors in other advanced nations in adopting
electronic medical records or prescribing medication electronically.”4
Indeed, only seventeen percent of physicians in ambulatory care settings5 use EHR systems to any extent, and only eleven percent of hospitals have fully implemented EHR systems.6
Medical errors have been estimated to result in as many as 98,000
deaths each year in the U.S. and to cost as much as $29 billion.7 Appropriate use of carefully designed EHR systems could dramatically
reduce those numbers. These systems can promote efficiency, diminish costs, save time, and save lives. For example, the Palo Alto Medical Foundation learned of Merck & Co.’s recall of certain batches of
hepatitis A vaccine that had lost their potency and was able, using its
1. An EHR is a record of “electronically maintained information about an individual’s
lifetime health status and health care, stored such that it can serve . . . multiple legitimate
users.” BIOMEDICAL INFORMATICS: COMPUTER APPLICATIONS IN HEALTH CARE AND
BIOMEDICINE 937 (Edward H. Shortliffe & James J. Cimino eds., 3d ed., Springer 2006)
(1990) [hereinafter BIOMEDICAL INFORMATICS]. EHR systems, as we are using the term, are
systems that add to EHR databases information management tools including clinical alerts,
reminders, decision aids, links to medical literature, and tools for data analysis, such as
search engines. See id.
2. INST. OF MED., KEY CAPABILITIES OF AN ELECTRONIC HEALTH RECORD SYSTEM 1–2
(2003) (stating that “[t]here is a great deal of interest within both the public and private
sectors in encouraging all health care providers to migrate from paper-based health records
to a system that stores health information electronically and employs computer-aided decision support systems” and that the “development of an IT infrastructure has enormous potential to improve the safety, quality, and efficiency of health care in the United States”); see
also THE LEWIN GROUP, HEALTH INFORMATION TECHNOLOGY LEADERSHIP PANEL FINAL
REPORT 3 (2005) (recognizing “HIT implementation as an essential, high priority for health
care”).
3. Editorial, World’s Best Medical Care?, N.Y. TIMES, Aug. 12, 2007, at WK9. France
and Italy were ranked first and second. Id.
4. Id. The editorial also argued that “despite our vaunted prowess in computers, software
and the Internet, much of our health care system is still operating in the dark ages of paper
records and handwritten scrawls.” Id.
5. Ambulatory care is treatment that is given at the office of a physician or other provider. See STEDMAN’S MEDICAL DICTIONARY 59 (28th ed. 2005) (defining “ambulatory” as
“denoting a patient who is not confined to bed or hospital as a result of disease or surgery”).
6. See AM. HOSP. ASS’N, CONTINUED PROGRESS: HOSPITAL USE OF INFORMATION
TECHNOLOGY 1 (2007), available at http://www.aha.org/aha/content/2007/pdf/070227continuedprogress.pdf; Catherine M. DesRoches et al., Electronic Health Records in Ambulatory Care — A National Survey of Physicians, 359 NEW ENG. J. MED. 50, 54 (2008). For
further discussion of how many health care providers currently use EHR systems, see infra
notes 149–53 and accompanying text.
7. TO ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM 1–2 (Linda T. Kohn et al.
eds., 2000).
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EHR system, to identify 17,000 patients who needed to be revaccinated.8
An emergency room doctor at a large Texas hospital also provided two vivid illustrations of the need for EHR systems from his
personal experience.9 In one case, a woman with a splint on her arm
stated that she had a broken arm, was suffering severe discomfort, and
had run out of the painkillers she was given when initially treated at
another hospital. In the absence of access to the other hospital’s records, the doctor ordered X-rays of her arm and neck, only to discover
that she had no injury. The time and expense wasted in uncovering the
woman’s scheme to obtain prescription narcotics could have been
avoided had the physician been able to discredit her claim through a
search of electronic records. In a second instance, the doctor treated a
paraplegic patient who had a urinary tract infection. Because he did
not have access to the patient’s records at other facilities, the physician did not know that the infection, caused by the patient’s permanent urinary catheter, was resistant to the antibiotics that he had
prescribed. The patient died of heart failure in the hospital.
Politicians and government leaders have expressed great enthusiasm for the development and implementation of EHR systems. In
April 2004, President George W. Bush announced plans to ensure that
most Americans’ health records are computerized within ten years10
and to create a National Health Information Network (“NHIN”).11
Numerous proposed bills have been introduced in Congress to promote HIT initiatives.12 Executive and legislative efforts at the state
level have established strategies and target dates for HIT implementation, commissions to develop recommendations for HIT use, and financial incentives for HIT adoption.13 EHR systems also became an
issue in the 2008 presidential campaign, as both Senators McCain and
Obama discussed their potential benefits.14
8. Meg Walker, Electronic Medical Records Can Cure Potential Nightmares, SAN
FRANCISCO BUS. TIMES, Mar. 29, 2002, available at http://sanfrancisco.bizjournals.com/
sanfrancisco/stories/2002/04/01/newscolumn2.html.
9. E-mail to Sharona Hoffman, Professor of Law, Case Western Reserve University Law
School (Aug. 29, 2007, 22:46:00 EDT) (on file with author).
10. The White House, A New Generation of American Innovation, Transforming Health
Care:
The
President’s
Health
Information
Technology
Plan,
http://www.whitehouse.gov/infocus/technology/economic_policy200404/chap3.html (last
visited Dec. 19, 2008).
11. Exec. Order No. 13,335, 69 Fed. Reg. 24,059 (Apr. 27, 2004); Nicolas P. Terry &
Leslie P. Francis, Ensuring the Privacy and Confidentiality of Electronic Health Records,
2007 U. ILL. L. REV. 681, 686.
12. See infra notes 160–62 and accompanying text.
13. National Conference of State Legislatures, Health Information Technology Financing
Legislation, http://www.ncsl.org/programs/health/forum/Hitch/finance.htm (last visited Dec.
19, 2008).
14. Editorial, The Candidates’ Health Plans, N.Y. TIMES, Oct. 28, 2008, at A30 ("Both
candidates have largely accepted the prevailing expert wisdom on ways to improve quality
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However, the novel and significant risks generated by EHR systems cannot be ignored.15 Products with poor information display and
navigation can impede rather than facilitate providers’ work.16 The
growing capabilities of EHR systems require increasingly complex
software, which heightens the danger of software failures that may
harm patients. To illustrate, one report relates that a hospital pharmacy’s computer program generated erroneous medication order lists,
leading to the delivery of the wrong drugs to patients in many wards.17
Thus far, the legal literature has not assessed the need for careful
regulatory oversight of EHR systems akin to that required, in principle, by the Food and Drug Administration (“FDA”) for life-critical
medical devices.18 This Article begins to fill that gap. It analyzes EHR
systems from both legal and technical perspectives and examines how
law can serve as a tool to promote HIT. Extensive regulations already
exist to govern the privacy and security of electronic health information.19 Privacy and security, however, are only two of the concerns
that merit regulatory attention. Perhaps even more important are the
safety and efficacy of these life-critical systems.
The benefits of EHR systems will outweigh their risks only if
these systems are developed and maintained with rigorous adherence
to the best software engineering and medical informatics practices and
if the various EHR systems can easily share information with each
other. Regulatory intervention is needed to ensure that these goals are
achieved. Once EHR systems are fully implemented, they become
essential to proper patient care, and their failure is likely to endanger
patient welfare.20
and lower health care costs over the long run, such as relying more on electronic medical
records and better management of the chronically ill.").
15. See infra notes 102–13 and accompanying text; INTEGRATED CTR. FOR CARE
ADVANCEMENT THROUGH RESEARCH ET AL., THE RELATIONSHIP BETWEEN ELECTRONIC
HEALTH RECORDS AND PATIENT SAFETY: A JOINT REPORT ON FUTURE DIRECTIONS FOR
CANADA 7 (2007), available at http://www.infoway-inforoute.ca/Admin/Upload/Dev/
Document/EHR-Patient%20Safety%20Report.pdf (asserting that there is “evidence to suggest that EHRs may facilitate medical errors and/or generate new kinds of errors”).
16. See Pamela Hartzband & Jerome Groopman, Off the Record — Avoiding the Pitfalls
of Going Electronic, 358 NEW ENG. J. MED. 1656, 1657 (2008) (“[I]n the new electronic sea
of results, it becomes difficult to find those that are truly relevant”); Christine A. Sinsky, eNirvana: Are We There Yet?, 15 FAM. PRAC. MGMT. 6, 6 (2008), available at
http://www.aafp.org/fpm/20080300/6enir.html (arguing that existing EHR systems have
severe usability problems and provide poor support to physicians).
17. Richard I. Cook & Michael F. O’Connor, Thinking About Accidents and Systems, in
IMPROVING MEDICATION SAFETY 80–82 (Kasey Thompson & Henri R. Manasse eds., 2005)
(explaining that the problem was rooted in a backup tape that was incomplete and corrupted).
18. See infra Part III.B.1 for discussion of FDA’s regulation of medical devices.
19. See infra notes 119–28 and accompanying text (discussing the HIPAA Privacy and
Security rules).
20. See Frank Richards, Infrastructure, in IMPLEMENTING AN ELECTRONIC HEALTH
RECORD SYSTEM 21, 21 (James M. Walker et al. eds., 2005) [hereinafter IMPLEMENTING AN
EHR SYSTEM] (explaining that “falling back on manual processes when the automated
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The remainder of the Article will proceed as follows: Part II provides background and analysis of EHR systems, including their benefits and risks. Part III assesses the need for regulatory oversight of
EHR systems. Part IV develops detailed recommendations for the
contents of a regulatory framework. These recommendations include a
requirement that all health care providers use approved EHR systems
and that the government provide financial assistance to support the
implementation of the new systems. In addition, the proposal addresses the following: the selection of an agency to regulate EHR systems; the creation of approval and monitoring processes for EHR
systems; the standardization of system features and capabilities; interoperability; and the establishment of a national research databank of
de-identified21 electronic patient records. Part V concludes.

II. EHR SYSTEMS: BACKGROUND AND ANALYSIS
A. What Are EHR Systems?
No universally accepted definitions have been developed for
“EHRs” or “EHR systems.”22 There is, however, some agreement
about their essential components.23 EHR systems, as the term is used
in this Article and by other commentators, do much more than keep
records.24 In 2003, the Institute of Medicine (“IOM”) identified the
following elements as “core EHR functionalities”:
•

•

Health information and data: The system should display laboratory test results, allergies, lists of other medications the
patient is taking, medical and nursing diagnoses, patient demographics, and providers’ notes.25
Results management: EHRs should provide laboratory test results, radiology procedure results, and other treatment results

system is down is problematic at best, and, in the worst case, may compromise patient
care”).
21. De-identified medical records are records that do not explicitly identify individuals
and cannot be used to identify individuals (e.g., through social security numbers, addresses,
etc.). See 45 C.F.R. § 164.514(a) (2007).
22. See Ashish K. Jha et al., How Common Are Electronic Health Records in the United
States? A Summary of the Evidence, 25 HEALTH AFF. w496, w497 (2006); see also ROBERT
WOOD JOHNSON FOUND. ET AL., HEALTH INFORMATION TECHNOLOGY IN THE UNITED
STATES: THE INFORMATION BASE FOR PROGRESS 8 (2006), available at
http://www.rwjf.org/files/
publications/other/EHRReport0609.pdf (noting the “need to develop a common, valid definition of an EHR”).
23. Jha et al., supra note 22, at w497.
24. See BIOMEDICAL INFORMATICS, supra note 1, at 937 (noting that EHR systems include “information management tools that provide clinical alerts and reminders, linkages
with external health knowledge sources, and tools for data analysis”).
25. INST. OF MED., supra note 2, at 7.
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electronically to enhance provider access to needed information and promote efficiency and easier detection of abnormalities.26
Order entry and management: Computerized medication orders and other care instructions can reduce or eliminate lost
orders, duplicate orders, mistakes caused by illegible handwriting, and delays in filling orders.27
Decision support: Computer reminders and prompts can improve preventive care, diagnosis, treatment, and disease management.28
Electronic communication and connectivity: EHR systems
should facilitate online communication among medical team
members, other providers such as laboratories or pharmacies,
and patients through e-mail, web messaging, integrated health
records within and across treatment settings, telemedicine,29
and home telemonitoring.30 Communication should be possible among providers in different geographic locations and
medical organizations.31

With these features, EHR systems can significantly improve medical treatment by ensuring that patients’ health information is easily
available to providers who require it, by preventing or correcting clinicians’ errors or oversights before they cause harm, and by helping to
promulgate best medical practices. In addition, EHR systems can
serve important administrative functions:
•
•

Patient support: Patient education and self-testing at home
should be facilitated by electronic systems.32
Administrative processes: Electronic scheduling systems, insurance eligibility verification, billing, and claims processing
systems should be components of EHRs. Computerized tools
can also be used to identify individuals who are potentially
eligible for clinical trials, those who should be informed
about a drug recall, or candidates for chronic disease management programs.33

26. Id. at 7–8.
27. Id. at 8.
28. Id. at 8–9.
29. Telemedicine is “the delivery of health care at a distance, increasingly but not exclusively by means of the Internet.” BIOMEDICAL INFORMATICS, supra note 1, at 991.
30. Home telemonitoring can be defined as “an automated process for the transmission of
data on a patient’s health status from home to the . . . health care setting.” Guy Paré et al.,
Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base, 14 J.
AM. MED. INFORMATICS ASS’N 269, 270 (2007).
31. INST. OF MED., supra note 2, at 9–10.
32. Id. at 10.
33. Id.
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Reporting and population health management: Through the
implementation of standardized terminology and machinereadable records, EHR systems should enable providers to
collect clinical data in order to meet public and private reporting requirements.34

The federal government’s ultimate goal is a fully interoperable
EHR system. The system will initially operate on a regional basis using Regional Health Information Organizations (“RHIOs”) and eventually transition to an NHIN.35 “Interoperability” means “the ability
for systems to exchange data and to operate in a coordinated, seamless
manner.”36 If EHR systems across the country are made interoperable,
patients who relocate to different cities or seek second opinions from
doctors outside their physician networks could have their records electronically transmitted to the new physicians, who could use them on
their own EHR systems.
One well known RHIO is the Regenstrief Medical Record System, which is used by numerous facilities in the Indianapolis area.37
The system captures medical data, includes an order entry mechanism,
provides reminders and informational feedback, and features search
and retrieval capabilities for research purposes.38 The largest EHR
system in the U.S. is the Veterans Health Information Systems and
Technology Architecture (“VistA”) developed by the Department of
Veterans’ Affairs (“VA”). A primary component of VistA is a physician interface called the Computerized Patient Record System
(“CPRS”).39 The CPRS, which has been widely praised,40 provides
complete EHRs, an order entry system, critical alerts, remote access to
health information at other VA facilities, and decision support, including reminders.41
34. Id. at 10–11.
35. Jeff Day, Regional EHR Exchanges to Lead U.S. Drive, Some Say; Others See Questionable Future, 15 BNA’S HEALTH CARE POL’Y REP. 1011, 1011 (2007); Terry & Francis,
supra note 11, at 686.
36. BIOMEDICAL INFORMATICS, supra note 1, at 952.
37. See Clement J. McDonald et al., The Regenstrief Medical Record System: A Quarter
Century Experience, 54 INT’L J. MED. INFORMATICS 225, 226–28 (1999).
38. Id. at 225–27, 248.
39. See Jonathan B. Perlin et al., The Veterans Health Administration: Quality, Value,
Accountability, and Information as Transforming Strategies for Patient-Centered Care,
10 AM. J. MANAGED CARE 828, 828, 832 (2004). See generally DEP’T OF VETERANS
AFFAIRS, COMPUTERIZED PATIENT RECORD SYSTEM (CPRS) USER GUIDE (2008) (on file
with the author) [hereinafter CPRS USER GUIDE] (describing the VA’s CPRS and its features).
40. See, e.g., Joel Kupersmith et al., Advancing Evidence-Based Care for Diabetes: Lessons from the Veterans Health Administration, 26 HEALTH AFF. w156, w156 (2007) (stating
that the VA’s Veterans Health Administration provides “a unique laboratory for using the
[EHR] to transform health care and accelerate discovery”); Perlin et al., supra note 39, at
832.
41. Perlin et al., supra note 39, at 832–33.
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Some current HIT initiatives utilize two alternatives to comprehensive EHRs: continuity of care records (“CCRs”) and personal
health records (“PHRs”).42 CCRs are summaries that aggregate data
from a variety of sources to form a limited record of the patient’s provider and insurance information, current health care status, and medical history, including allergies, medications, diagnoses, and recent
procedures.43 These subsets of full patient EHRs can be e-mailed to
the patient’s next care giver or given to the patient on paper or portable electronic media to be taken to her next appointment.44 While
useful, CCRs are not as comprehensive as full EHRs, and, unlike
EHR systems, CCRs do not offer order entry mechanisms, decision
support, or interoperability, all of which provide significant benefits to
patients and clinicians.45
PHRs contain medical and claims information that is collected
and maintained by patients who may then share this information with
other parties, including employers, insurers, and private enterprises.46
One source describes the PHR as follows:
[A]n Internet-based set of tools that allows people to
access and coordinate their lifelong health information and make appropriate parts of it available to
those who need it. PHRs offer an integrated and
comprehensive view of health information, including
information people generate themselves such as
symptoms and medication use, information from
doctors such as diagnoses and test results, and information from their pharmacies and insurance companies. Individuals access their PHRs via the

42. Terry & Francis, supra note 11, at 687–88.
43. CTR. FOR HEALTH INFO. TECH., ESSENTIAL SIMILARITIES AND DIFFERENCES
BETWEEN THE HL7 CDA/CRS AND ASTM CCR 1–2 (2005), available at
http://www.centerforhit.org/PreBuilt/chit_ccrhl7.pdf; Lynda C. Burton et al., Using Electronic Health Records to Help Coordinate Care, 82 MILBANK Q. 457, 461 (2004).
44. Burton et al., supra note 43, at 461.
45. See supra note 36 and accompanying text (discussing interoperability); infra Parts
II.B.2, IV.C.2, and IV.C.5 (discussing computerized order entry, decision support, and
interoperability).
46. Terry & Francis, supra note 11, at 688; see also Private Health Records: Privacy Implications of the Federal Government’s Health Information Technology Initiative: Hearing
Before the S. Comm. on Homeland Security and Governmental Affairs, 110th Cong. 5–6
(2007) [hereinafter Private Health Records] (testimony of Mark A. Rothstein, Director,
University of Louisville School of Medicine), available at http://hsgac.senate.gov/
public/_files/testimonyrothstien.pdf; Press Release, BlueCross BlueShield Association,
BlueCross Introduces Personal Health Record for Fully-Insured Members (Sept. 20, 2006),
available
at
http://www.bcbs.com/news/plans/bluecross-introduces-personal-healthrecords.html.
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Internet, using state-of-the-art security and privacy
controls . . . .47
Wal-Mart and other large employers, such as Intel and BP, with a
total of 2.5 million employees, have formed a PHR system named
Dossia.48 Both Google and Microsoft have developed products that
enable customers to maintain PHRs.49
However, stand-alone PHRs may be of limited use. To the extent
data is entered by patients themselves, they may often be incomplete
or inaccurate.50 Furthermore, without interoperability and the capacity
to exchange data with EHR systems operated by all facilities at which
the patient receives care, PHRs would constitute isolated and partial
records, because they could not be accessed by all physicians and
could not be updated with each new patient encounter.51 Finally,
stand-alone PHRs will not offer some of the most important benefits
of EHR systems, including decision support and order entry. Consequently, some commentators assert that PHRs will be of significant
benefit to patients and caregivers only if they are integrated into providers’ EHR systems.52
B. Benefits of EHR Systems
Many experts have justifiably expressed strong enthusiasm for
EHR systems, and many policy makers have asserted a commitment
to promote their broad adoption.53 These systems could facilitate clinicians’ access to critical patient information and could prevent medi-

47. PERSONAL HEALTH WORKING GROUP, MARKLE FOUND., THE PERSONAL HEALTH
WORKING GROUP FINAL REPORT 3 (2003), available at http://www.markle.org/
downloadable_assets/final_phwg_report1.pdf.
48. Private Health Records, supra note 46, at 6.
49. See Steve Lohr, Dr. Google and Dr. Microsoft, N.Y. TIMES, Aug. 14, 2007, at C1;
see also Martha Kessler, Aetna Joins With Microsoft to Provide Portable Health Records
for Members, 16 BNA’S HEALTH CARE POL’Y REP. 1456 (2008); Google Health,
http://www.google.com/health (last visted Dec. 19, 2008); Posting of Steve Lohr to NYTimes.com Bits Blog, Google Health Begins Its Preseason at Cleveland Clinic,
http://bits.blogs.nytimes.com/2008/02/21/google-health-begins-its-preseason-at-clevelandclinic (Feb. 21, 2008, 1:13 EST) (discussing a pilot project in which the health information
of ten thousand Cleveland Clinic patients would be linked with Google PHRs).
50. Paul C. Tang et al., Personal Health Records: Definitions, Benefits, and Strategies
for Overcoming Barriers to Adoption, 13 J. AM. MED. INFORMATICS ASS’N 121, 122 (2006)
(asserting that “it is unlikely that individuals would keep records . . . up to date” and that
“most patients cannot reliably report specific laboratory values such as their specific cholesterol level or hemoglobin A1c”).
51. Id. at 124 (explaining that PHRs could “become ‘information islands’ that contain
subsets of patients’ data, isolated from other information about patients, with limited access
and transient value”).
52. See, e.g., id. (“[A]ll the advantages of PHRs for providers depend on the PHR being
integrated with the provider’s EHR.”).
53. See supra notes 10–14 and accompanying text.
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cal errors, thereby potentially saving thousands of lives and billions of
dollars.54
This Section describes the numerous benefits of EHR systems,
which could dramatically improve health care in the U.S. and worldwide. These benefits support the widespread adoption of EHR systems and the establishment of an NHIN.
1. Facilitating Access to Patients’ Medical Records
EHR systems enable health care providers to obtain critical medical information about their patients as soon as the need for it arises.
Essential to this capacity is interoperability.55
Interoperable EHR systems could allow doctors with proper authorization to access to relevant information about their patients, including medical histories, drug lists, and allergies, no matter where
the patients had been previously treated. This capability could be invaluable in treating patients who arrive at the emergency room unconscious. It could also significantly facilitate and enhance the treatment
of economically disadvantaged patients, who may not have attentive
primary care physicians to manage their care56 and who may not fully
recall or understand the details of their medical histories.
Many patients who are not economically disadvantaged also have
records that are fragmented and not fully accessible to all physicians
treating them. According to one source, the average patient on Medicare visits seven different physicians every year.57 If these doctors do
not communicate and carefully coordinate the patient’s care, any one
of them may miss vital information that is critical to the individual’s
welfare.
An additional strength of EHRs is that, if appropriately backed up
or replicated, they should be less vulnerable to loss or destruction than
paper records. This problem with paper records was highlighted in the
aftermath of Hurricane Katrina, when the medical records of many
displaced New Orleans residents were destroyed.58

54. See TO ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM, supra note 7, at 1–2.
55. See supra note 36 and accompanying text.
56. See Lawrence O. Gostin, “Police” Powers and Public Health Paternalism: HIV and
Diabetes Surveillance, 37 HASTINGS CENTER REP. 9, 10 (2007) (“Most poor people do not
enjoy the benefits of education and income that enable them to form stable physician-patient
relationships and comply with complex treatment regimes.”).
57. DANIEL CASTRO, INFO. TECH. & INNOVATION FOUND., IMPROVING HEALTH CARE:
WHY A DOSE OF IT MAY BE JUST WHAT THE DOCTOR ORDERED 3 (2007), available at
http://www.itif.org/files/HealthIT.pdf.
58. See Olga Pierce, Analysis: The Medical Record Paper Chase, UPI, Sept. 15, 2006,
LEXIS, News Library, UPI File; see also Jeff Day, Group Finds Support for E-Health Records, ‘Medical Home’ Clinics Following Hurricane, 15 BNA’S HEALTH CARE POL’Y REP.
716, 716 (2007).
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2. Improving Quality of Care and Reducing Poor Treatment Decisions
EHR systems can reduce errors and thereby improve patient safety, particularly through decision support features.59 Decision support
is “any information added by a system to assist the clinician’s decision-making process.”60 EHR systems can incorporate reminders,
prompts, and links to medical literature to promote accurate, timely,
and responsible care.61 Studies have shown that computerized reminder systems improve immunization rates, preventive care, clinician adherence to practice guidelines, and the thoroughness of patient
histories. Studies have also shown that EHR systems reduce prescribing costs, prescribing mistakes, and unneeded diagnostic tests.62 According to one source, computerized physician order entry (“CPOE”)
systems could likely prevent sixty-five percent of prescribing errors,
largely by incorporating decision support features that would educate
doctors about medications.63 In one instance, for example, a doctor
typed a prescription for ten times the proper dosage, and the EHR system informed him of the error.64

59. See Basit Chaudhry et al., Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care, 144 ANNALS INTERNAL MED. 742,
748 (2006) (citing the benefits of “increased delivery of care based on guidelines . . . , reduction of medication errors, and decreased rates of utilization for potentially redundant or
inappropriate care”); see also INST. OF MED., supra note 2, at 5. But see infra Part II.C.1 for
discussion of the possibility that EHR systems might sometimes cause errors instead of
preventing them.
60. Jonathan A. Handler et al., Computerized Physician Order Entry and Online Decision
Support, 11 ACAD. EMERGENCY MED. 1135, 1135 (2004).
61. See Anne Bobb et al., The Epidemiology of Prescribing Errors: The Potential Impact
of Computerized Prescriber Order Entry, 164 ARCHIVES INTERNAL MED. 785, 788–89
(2004); Richard Hillestad et al., Can Electronic Medical Record Systems Transform Health
Care? Potential Health Benefits, Savings, and Costs, 24 HEALTH AFF. 1103, 1110 (2005);
Jeffrey A. Linder, Health Information Technology as a Tool to Improve Care for Acute
Respiratory Infections, 10 AM. J. MANAGED CARE 661, 661 (2004).
62. See Burton et al., supra note 43, at 461, 464; see also Paul R. Dexter et al., A Computerized Reminder System to Increase the Use of Preventive Care for Hospitalized Patients, 345 NEW ENG. J. MED. 965, 968 (2001) (finding that “the use of reminders increased
the use of pneumococcal and influenza vaccination from practically zero to approximately
35 percent and 50 percent, respectively” for hospitalized patients); Elizabeth Mitchell &
Frank Sullivan, A Descriptive Feast but an Evaluative Famine: Systematic Review of Published Articles on Primary Care Computing During 1980–97, 322 BRIT. MED. J. 279, 281
(2001) (describing “improvements in immunisations and preventive care and reductions in
prescribing costs and unnecessary tests” due to computerization); Mike Pringle, Using Computers to Take Patient Histories, 297 BRIT. MED. J. 697, 697 (1988) (“Computer histories
are more exhaustive than those taken in the normal way.”); Charles Safran et al., Guidelines
for Management of HIV Infection with Computer-Based Patient’s Records, 346 LANCET
341, 344 (1995) (concluding that EHR systems help clinicians to adhere to practice guidelines).
63. Bobb et al., supra note 61, at 788.
64. Ceci Connolly, Cedars-Sinai Doctors Cling to Pen and Paper, WASH. POST, Mar. 21,
2005, at A01.
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EHR systems might also dissuade physicians from practicing
wasteful “defensive medicine.”65 Clinicians could rely on decision
support mechanisms to determine whether particular diagnostic procedures or treatments are warranted. Because these mechanisms
would be designed based on widely accepted medical practices, the
doctors could, if necessary, cite their reliance on the mechanisms to
defend their medical decisions.
Likewise, the systems could reduce the unnecessary use of antibiotics. One study found that seventy-three percent of adults who visit
primary care physicians for sore throats are treated with antibiotics,
even though only five to seventeen percent of adults’ sore throats require antibiotic therapy.66 The excessive use of broad spectrum antibiotics has led to the emergence of antibiotic-resistant bacteria.67 This
phenomenon might become less common with the assistance of decision support systems designed to provide guidance concerning prescription drugs.
Currently, the lag between the discovery of new treatments and
their consistent use in medical practice can be up to twenty years.68
EHR systems, however, could significantly expedite the broad dissemination of knowledge about effective new treatments through decision support mechanisms.69
Furthermore, by allowing physicians to search patient records
electronically for the information they require, EHR systems can reduce the amount of time providers spend reviewing patients’ medical
histories.70 In addition, electronic searches can allow clinicians to

65. See David M. Studdert et al., Defensive Medicine Among High-Risk Specialist Physicians in a Volatile Malpractice Environment, 293 JAMA 2609, 2609 (2005) (noting that
defensive medicine is prevalent among Philadelphia physicians in specialties with a high
risk of litigation). “Defensive medicine” is the practice of making healthcare decisions “with
the sole intention of preventing” malpractice lawsuits and can include the provision of excessive unnecessary care or the avoidance of beneficial treatment that is high-risk. G.D.
Dalton et al., Effect of Physician Strategies for Coping with the US Medical Malpractise
Crisis on Healthcare Delivery and Patient Access to Healthcare, 122 PUB. HEALTH 1051,
1054–55 (2008).
66. Jeffrey A. Linder & Randall S. Stafford, Antibiotic Treatment of Adults With Sore
Throat by Community Primary Care Physicians: A National Survey 1989–1999, 286 JAMA
1181, 1185 (2001) (providing statistics regarding the use of antibiotics); see also Richard E.
Besser, Editorial, Antimicrobial Prescribing in the United States: Good News, Bad News,
138 ANNALS INTERNAL MED. 605, 605 (2003) (“[I]n 1992, the U.S. Centers for Disease
Control and Prevention (CDC) stated that over 40% of antimicrobial courses prescribed in
physicians’ offices were inappropriate.”).
67. See Besser, supra note 66, at 605.
68. COMM. ON QUALITY OF HEALTH CARE IN AM., INST. OF MED., CROSSING THE
QUALITY CHASM: A NEW HEALTH SYSTEM FOR THE 21ST CENTURY 145 (2001) [hereinafter
CROSSING THE QUALITY CHASM].
69. See Louise Liang, The Gap Between Evidence and Practice, 26 HEALTH AFF. w119,
w120 (2007).
70. See Richard J. Baron et al., Electronic Health Records: Just Around the Corner? Or
over the Cliff?, 143 ANNALS INTERNAL MED. 222, 225–26 (2005).
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identify patients who should be informed about matters such as drug
recalls.71
Of particular significance is the potential role of these systems in
reducing health disparities in the U.S.72 Health disparities between
whites and blacks have been the subject of much commentary and
debate in recent years.73 Technology that provides resource-poor practices with automatic decision support, reminders, and alerts based on
the most advanced medical knowledge could enhance the care available to economically disadvantaged patients. With affordable or subsidized EHR systems, clinicians who are pressed for time and
resources would have information at their fingertips that they might
otherwise be unable to access. It must be noted, however, that, if only
wealthy practices can afford EHR systems and others are left without
the improvements they enable, the technology could increase health
disparities between rich and poor communities. Consequently, it will
be important to offer financial support for EHR system adoption to
some practices.74
EHR systems also have much to contribute to public health emergency response efforts. EHR vendors75 and public health officials
could use decision support functions in EHR systems to inform clinicians as to how best to respond to public health emergencies.76 For
example, EHR systems nationwide might be quickly reconfigured to
advise caregivers to treat patients with particular symptoms as possible carriers of an emerging infectious disease.
3. Cost Savings
Many commentators associate significant cost savings with EHR
systems, despite the expenses of purchasing, implementing, and oper71. See id.
72. See Alexandra E. Shields et al., Adoption of Health Information Technology in Community Health Centers: Results of a National Survey, 26 HEALTH AFF. 1373, 1381 (2007)
(stating that expanding HIT capacity “seems a valuable strategy to further reduce health
disparities for a substantial number of financially vulnerable patients”).
73. See, e.g., René Bowser, Racial Profiling in Health Care: An Institutional Analysis of
Medical Treatment Disparities, 7 MICH. J. RACE & L. 79, 81 (2001) (positing an institutional basis for white-black disparities in medical treatment); Ichiro Kawachi et al., Health
Disparities by Race and Class: Why Both Matter, 24 HEALTH AFF. 343 (2005) (examining
racial and class disparities in health); David Satcher et al., What if We Were Equal? A Comparison of the Black-White Mortality Gap in 1960 and 2000, 24 HEALTH AFF. 459 (2005)
(discussing persistent racial inequalities in standardized mortality ratios over a forty year
period).
74. See infra Part IV.A.1.
75. Throughout this Article we use the term “vendor” broadly to refer to those who develop or modify EHR system software, install it, or integrate it with existing systems. Health
care providers who perform these functions themselves should be deemed vendors for legal
purposes relating to EHR system activities ordinarily performed by vendors.
76. These adaptations could be similar to automatic anti-virus downloads, which are now
commonly available.
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ating them.77 Some commentators have estimated the net economic
benefits of EHR implementation to range from $8400 to $140,100 per
physician over five years.78 Others have found savings of $16.7 million over ten years for a hospital operating a CPOE system.79 Still
others have estimated $77.8 billion a year in savings for the institution
of a standardized, interoperable national system.80 These cost savings
result from: fewer duplicated tests; reduction in administrative expenditures; a decrease in medical errors and adverse drug events linked to
ignorance about the patient’s allergies, medical history, and other prescription drugs; and, from the provider’s perspective, from improved
mechanisms for calculating and recording charges.81 Doctors would
be able to retrieve the EHRs of patients who present at emergency
rooms no matter where those records are housed and thus would not
need to conduct diagnostic tests that the patient has already recently
undergone. Furthermore, access to a patient’s complete EHR, including medical history, allergies, and current medication list, could prevent medical errors in the emergency room that might lead to lengthy
hospitalization, surgery, and other expensive care.
Other commentators note, however, that to date there is a dearth
of compelling empirical evidence that proves the cost-effectiveness of
EHR systems.82 Indeed, because of the relatively low rate of EHR
system adoption, to date there is only limited data concerning cost
savings.83 The evidence base is likely to improve as more institutions
adopt EHR systems and an increasing number of researchers and
economists begin to study their impact.

77. See infra notes 131–33 and accompanying text for discussion of these costs.
78. William W. Stead, Rethinking Electronic Health Records to Better Achieve Quality
and Safety Goals, 58 ANN. REV. MED. 35, 37 (2007).
79. Rainu Kaushal et al., Return on Investment for a Computerized Physician Order Entry System, 13 J. AM. MED. INFORMATICS ASS’N 261, 265 (2006).
80. Jan Walker et al., The Value of Health Care Information Exchange and Interoperability, 25 HEALTH AFF. W5-10, W5-16 (2005). For a critique of estimates of savings generated
by the proposed NHIN, see CONG. BUDGET OFFICE, EVIDENCE ON THE COSTS AND
BENEFITS OF HEALTH INFORMATION TECHNOLOGY 8 (2008), available at
http://www.cbo.gov/
ftpdocs/91xx/doc9168/05-20-HealthIT.pdf (discussing “estimates of the potential net benefits that could arise nationwide if all providers and hospitals adopted health information
technology”).
81. See CONG. BUDGET OFFICE, supra note 80; Kaushal et al., supra note 79, at 263 tbl.1;
Walker et al., supra note 80, at W5-16.
82. S. Clamp & J. Keen, Electronic Health Records: Is the Evidence Base Any Use?,
32 MED. INFORMATICS & INTERNET MED. 5, 9 (2007) (stating that the authors “found no
technically sound evidence about cost changes associated with EHR”).
83. Hillestad et al., supra note 61, at 1104 (“[T]he currently useful evidence [concerning
HIT efficiency savings] is not robust enough to make strong predictions . . . .”).
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4. Promoting Research
EHRs could also promote medical research and the collection of
much needed evidence concerning the efficacy of various treatment
alternatives.84 The term of art for decision-making rooted in scientific
knowledge is “evidence-based medicine,”85 a concept that is now frequently discussed in academic and scientific circles.86 First, EHRs
could facilitate the identification of patients for clinical studies by
allowing investigators to search their patient records electronically for
individuals who meet the inclusion criteria for particular clinical trials. Second, many studies could be based directly on analysis of the
extensive and comprehensive data contained in electronic records.87
EHR systems should facilitate efficient and extensive collection of
evidence and development of new knowledge.88
Randomized, controlled clinical trials are considered the gold
standard of medical studies.89 However, research can also be accomplished through observational studies, which could be facilitated by
the use of EHRs.90 Rather than conducting a controlled experiment,
investigators might review the charts or electronic files of patients
receiving different medications or different types of surgery to treat a

84. See sources cited infra notes 386–87 (discussing the uncertainty surrounding many
medical decisions).
85. See Marc A. Rodwin, The Politics of Evidence-Based Medicine, 26 J. HEALTH POL.
POL’Y & L. 439, 439 (2001) (explaining that “[e]vidence-based medicine is portrayed as an
alternative to medicine based on authority, tradition, and the physician’s personal experience” and that it involves evaluating the “safety, effectiveness, and cost of medical practices
using tools from science and social science”).
86. See, e.g., Scott R. Sehon & Donald E. Stanley, A Philosophical Analysis of the Evidence-Based Medicine Debate, 3 BMC HEALTH SERVICES RES. (2003),
http://www.biomedcentral.com/1472-6963/3/14 (arguing that the medical community must
clarify the “nature of [evidence-based medicine] and its relationship to alternative approaches to medicine”).
87. See John Powell & Iain Buchan, Electronic Health Records Should Support Clinical
Research, 7 J. MED. INTERNET RES. (2005), available at http://www.jmir.org/2005/1/e4/.
88. Liang, supra note 69, at w120.
89. Friedrich K. Port, Role of Observational Studies Versus Clinical Trials in ESRD Research, 57 KIDNEY INT’L (SUPPLEMENT 74) S3, S3 (2000), available at
http://www.nature.com/ki/journal/v57/n74s/pdf/4491615a.pdf (“Randomized controlled
clinical trials have been considered by many to be the only reliable source for information in
health services research.”). Experimental studies involve “the collection of data on a process
when there is some manipulation of variables that are assumed to affect the outcome of a
process, keeping other variables constant as far as possible.” BRYAN F.J. MANLY, THE
DESIGN AND ANALYSIS OF RESEARCH STUDIES 1 (1992).
90. CHARLES P. FRIEDMAN & JEREMY C. WYATT, EVALUATION METHODS IN
BIOMEDICAL INFORMATICS 369 (2d ed. 2006) (defining an observational study as an
“[a]pproach to study design that entails no experimental manipulation” in which
“[i]nvestigators typically draw conclusions by carefully observing [subjects] with or without
an information resource”); MANLY, supra note 89, at 1 (explaining that observational studies involve the collection of data “by observing some process which may not be wellunderstood”).
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particular condition in order to determine the efficacy of each approach.91
At times, observational studies may be skewed by uncontrolled
variables, such as changes in diet, exercise, stress level, or other lifestyle modifications that are not noted in the record and of which researchers remain unaware.92 However, observational studies may also
have several advantages over clinical trials. Interoperable systems can
allow researchers to access vast amounts of information about various
subpopulations over long periods of time.93 Researchers can monitor
patients for years after drugs have been approved by the FDA and
detect patterns of adverse events, avoiding continued harm to patients
such as that caused by ignorance about the side effects of Vioxx.94
These studies can also be considerably less costly and timeconsuming than experimental research because the data used already
exist95 and investigators need not comply with federal research regulations or obtain approval from Institutional Review Boards (“IRBs”)96
if records are de-identified.97 In addition, investigators could study the
cases of individuals with very rare diseases that cannot be studied
through large-scale clinical trials. Likewise, researchers could review
the records of patients who receive care of varying quality, including
substandard care. Such substandard care, which is at times provided in
real world treatment settings, would not be provided in the controlled
setting of a clinical trial.
It is not anticipated that EHR-based observational studies would
replace randomized clinical trials.98 However, observational studies
are a valuable addition to the research toolkit.99 In the words of one
91. See, e.g., Kjell Benson & Arthur J. Hartz, A Comparison of Observational Studies
and Randomized, Controlled Trials, 342 NEW ENG. J. MED. 1878, 1879–83 (2000).
92. See MANLY, supra note 89, at 4–5 (“[A] prima facie conclusion may be invalid because of the confounding effects of uncontrolled variables.”); Benson & Hartz, supra note
91, at 1878 (“Concern about inherent bias [in observational studies] has limited their use in
comparing treatments”); Gary Taubes, Do We Really Know What Makes Us Healthy?, N.Y.
TIMES, Sept. 16, 2007, § 6 (Magazine), at 52 (describing the limitations of observational
studies and stating that they “can only provide what researchers call hypothesis-generating
evidence — what a defense attorney would call circumstantial evidence”).
93. See Liang, supra note 69, at w120 (“EHRs have the potential to take over where clinical trials and evidence-based research leave off, by providing real-world evidence of drugs’
and treatments’ effectiveness across subpopulations and over longer periods of time.”).
94. Lynn M. Etheredge, A Rapid-Learning Health System, 26 HEALTH AFF. w107, w111
(2007).
95. Benson & Hartz, supra note 91, at 1878; Port, supra note 89, at S3.
96. 21 C.F.R. § 56.102(g) (2007) (“Institutional Review Board (IRB) means any board,
committee, or other group formally designated by an institution to review, to approve the
initiation of, and to conduct periodic review of, biomedical research involving human subjects.”).
97. See infra note 394 and accompanying text (discussing regulatory requirements for the
approval of research studies).
98. See, e.g., Etheredge, supra note 94, at w108.
99. See Port, supra note 89, at S5 (arguing that both observational studies and clinical
studies have their place and complement each other); see also Jerry Avorn, In Defense of
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commentator, EHRs “will offer the capacity for real-time learning
from the experience of tens of millions of people and will greatly increase the ability to generate and test hypotheses.”100
C. The Challenges of EHR System Implementation
Despite the many potential benefits of EHR systems, they are not
an unalloyed good. Their design, implementation, use, and maintenance raise important concerns that must not be overlooked. EHR
system failures can cause significant injury and cost lives. Unauthorized disclosure of electronic health information can also lead to large
scale privacy breaches, and the cost of implementing EHR systems
may threaten the financial viability of some medical practices. The
risks generated by these complex software systems are sufficiently
serious that they demand regulatory oversight.101
1. Potential for Errors
In some instances, EHR systems may generate errors rather than
prevent them, especially early in the adoption process.102 Many of
these errors could significantly harm patients. One study of a hospital’s CPOE system identified twenty-two circumstances in which
CPOE increased rather than decreased the likelihood of error.103
Sources of such errors include: fragmentation of data; failure to integrate all hospital systems; and human-computer interface difficulties
rooted in the machine rules’ failure to reflect work organization or
expected provider behavior.104 For example, errors can result from
computer crashes or from maintenance shutdowns that lead to lost
orders.105 They may also result from system inflexibilities that significantly impede providers’ ability to enter nonstandard specifications or
Pharmacoepidemiology — Embracing the Yin and Yang of Drug Research, 357 NEW ENG.
J. MED. 2219, 2220 (2007) (listing the strengths and weaknesses of clinical and observational studies of medications); Benson & Hartz, supra note 91, at 1878, 1884 (concluding,
based on a literature review, that “observational studies and randomized controlled trials
usually produce similar results”).
100. Etheredge, supra note 94, at w108.
101. See infra Part III.A.2 (arguing for regulatory oversight of EHR systems).
102. See Stead, supra note 78, at 38.
103. Ross Koppel et al., Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors, 293 JAMA 1197, 1199–201 (2005).
104. Stead, supra note 78, at 38 (discussing human-computer interface problems); see
Jonathan R. Nebeker et al., High Rates of Adverse Drug Events in a Highly Computerized
Hospital, 165 ARCHIVES INTERNAL MED. 1111, 1114–15 (2005) (finding high rates of error
at a hospital whose CPOE system did not have adequate decision support); Robert L. Wears,
Computer Technology and Clinical Work, 293 JAMA 1261, 1262 (2005) (explaining that
“the model of health care work inscribed” in CPOE and decision support systems clashes
“with the actual nature of clinical work”).
105. Koppel et. al., supra note 103, at 1201.
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to order non-formulary medications.106 Usability problems, such as
display and navigation deficiencies, can also cause errors.107
Furthermore, complex software systems invariably exhibit a significant degree of coupling or interdependence between their many
components. Consequently, a failure of one component may cause or
contribute to the failure of another component that is not obviously
related to the first component.108 Similarly, complex software sometimes fails unpredictably due to unforeseen or untested interactions
between its various features and services.109 Under certain conditions,
a clearly safety-critical component of an EHR system, such as a diagnostic aid for cardiac care, might function incorrectly because of a
subtle interaction with an apparently unrelated defective component,
such as a billing feature.110
Other errors may cause physicians to absorb financial losses. One
physician reported that billing interface errors caused many of his
patients to be improperly categorized as established rather than new
patients, which resulted in a $90,000 revenue loss.111
Some failures caused by flawed software design, implementation,
or validation could be avoided with improved software engineering
practices.112 However, as EHR system functionality becomes more
complex, the safety risks to patients may grow unless additional quality control interventions are initiated.113

106. Id. Nonformulary medications are “[d]rugs not on a [health care] plan-approved
drug list.” Medicare.gov — Glossary Definitions, http://www.medicare.gov/Glossary/
search.asp?SelectAlphabet=N&Language=English#Content (last visited Dec. 19, 2008).
107. See Hartzband & Groopman, supra note 16, at 1657.
108. See John Rushby, Critical System Properties: Survey and Taxonomy,
43 RELIABILITY ENGINEERING & SYS. SAFETY 189, 210 (1994) (discussing coupling and
explaining how tightness of coupling promotes efficiency but can cause unexpected failures
in various system components).
109. Dirk O. Keck & Paul J. Kuehn, The Feature and Service Interaction Problem in
Telecommunications Systems: A Survey, 24 IEEE TRANSACTIONS ON SOFTWARE
ENGINEERING 779, 779–80 (1998).
110. Undesirable coupling and complex interactions between software components can
be reduced by the application of certain software design techniques such as object-oriented
design, but dependencies between components are an inherent aspect of software systems
and cannot be eliminated or rendered insignificant. ERICH GAMMA ET AL., DESIGN
PATTERNS: ELEMENTS OF REUSABLE OBJECT-ORIENTED SOFTWARE 24–25 (1999) (discussing design patterns that reduce coupling).
111. Ken Terry, IT Implementation: Why EHRs Falter, MED. ECON., April 7, 2006, at 44,
available at http://www.memag.com/memag/content/printContentPopup.jsp?id=316528.
112. Madhavan Nayar & Sharon Miller, Anticipating Error: Identifying Weak Links in
the Electronic Healthcare Environment, 75 J. AM. HEALTH INFO. MGMT. ASS’N 46, 47–49
(2004) (discussing various factors that are intrinsic and extrinsic to EHR systems and create
risks of error).
113. See infra Parts IV.B and IV.C for recommendations.
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2. Privacy and Security Concerns
Both patients and analysts have expressed concern that EHR systems will threaten patient privacy and be vulnerable to security
breaches.114 With a fully interoperable NHIN, EHRs could be accessed from anywhere in the country and transmitted illicitly across
the world quickly, cheaply, and with little risk of detection.115 The
security of health information is, in fact, compromised with alarming
frequency as a result of computer theft, sale of used computers without removal of data from hard drives, hacking, inadvertent disclosures, and deliberate misuse of information by those with access to
it.116 As an example, Georgetown University Hospital suspended a
test program with electronic prescription provider InstantDx after a
serious security breach was discovered in 2006.117 The hospital had
securely transmitted data concerning thousands of patients to InstantDx, but, because of InstantDx’s flawed security practices, an
Indiana consultant was able accidentally to stumble upon the online
files while installing medical software for a client.118
To address privacy and security concerns related to personal
health information, the U.S. Department of Health and Human Services (“HHS”) promulgated the Health Insurance Portability and Accountability Act (“HIPAA”) Privacy Rule119 and the HIPAA Security
Rule,120 the latter of which governs the security of certain electronic
health information.121 We have critiqued these regulations at length in
prior work and noted their shortcomings.122 The Privacy Rule covers
only a narrow range of entities, namely health plans, health care clearinghouses, and health care providers who transmit health information
electronically for claims, billing, or health plan purposes.123 It does
not cover employers, marketers, life insurers, or many others who
might handle personal health information. The Privacy Rule also does
114. Terry & Francis, supra note 11, at 696; National Committee on Vital and Health
Statistics, Privacy and Confidentiality in the Nationwide Health Information Network 8–13
(June 22, 2006), http://ncvhs.hhs.gov/060622lt.htm [hereinafter NCVHS] (“Protecting the
confidentiality of personal health information in such settings requires institutions to establish different access rules depending on employees’ responsibilities and their need to know
the information to carry out their role.”).
115. Sharona Hoffman & Andy Podgurski, Securing the HIPAA Security Rule, J.
INTERNET L., Feb. 2007, at 1, 6.
116. Id. at 6.
117. Kevin Poulsen, E-Health Gaffe Exposes Hospital, WIRED, July 25, 2006,
http://www.wired.com/science/discoveries/news/2006/07/71453.
118. Id.
119. 45 C.F.R. §§ 160.101−.534 (2007).
120. 45 C.F.R. §§ 160.302−.318 (2007).
121. See Sharona Hoffman & Andy Podgurski, In Sickness, Health, and Cyberspace:
Protecting the Security of Electronic Private Health Information, 48 B.C. L. REV. 331, 338–
44 (2007) (discussing the HIPAA Security Rule).
122. Id. at 344–59.
123. 45 C.F.R. § 160.103 (2007).
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not feature a private cause of action,124 so its deterrent and remedial
effects are limited.125 In addition, the Security Rule’s standards are
extremely vague, leaving a vacuum of guidance that makes meaningful compliance unlikely.126 A 2007 assessment of HIPAA compliance
in fact found widespread confusion and mistakes.127 The standards in
the HIPAA Privacy and Security Rules must be clarified, and their
enforcement must be bolstered so that patient privacy and EHR confidentiality are meaningfully protected.128
Many states also have medical confidentiality rules that will affect EHR systems.129 Because the NHIN would be an interstate network allowing data that is entered in one location to be accessed
anywhere in the U.S., some of the state standards may cause significant complications and require modification in light of HIT developments.130
3. Expense, Time, and Burden
The introduction of EHR systems into medical practice can involve significant costs and difficulties. The purchase of an EHR system is estimated to cost $33,000 per doctor, with an additional $1500
124. See 45 C.F.R. §§ 160.300−.552 (2007).
125. As of December 31, 2007, HHS received 32,487 complaints of HIPAA Privacy Rule
violations. See Privacy — Compliance and Enforcement, http://www.hhs.gov/ocr/privacy/
enforcement/numbersglance.html (last visited Dec. 19, 2008). However, no civil fines had
been imposed, and only four criminal actions had been brought under HIPAA’s criminal
enforcement provision. See Tresa Baldas, Hospitals Fear Privacy Claims Over Medical
Records, NAT’L L.J., May 28, 2007, at 4, 4.
126. Hoffman & Podgurski, supra note 121, at 350–54.
127. HIPAA Compliance Strategies: National Review of HIPAA Compliance Finds Rampant Confusion, Mistakes, REP. ON PATIENT PRIVACY (Atl. Info. Servs., Inc., Washington,
D.C.),
May
2007,
available
at
http://www.aishealth.com/Compliance/Hipaa/
RPP_National_Review_Rampant_Mistakes.html.
128. Hoffman & Podgurski, supra note 121, at 359–84 (developing recommendations for
the improvement of the HIPAA Privacy and Security Rules). A recently proposed bill, the
Health-e Information Technology Act, H.R. 6898, 110th Cong. §§ 400–15 (2008), would
bolster privacy and security safeguards. See THE HON. PETE STARK, CHAIRMAN, H. COMM.
ON WAYS AND MEANS, SUBCOMM. ON HEALTH, PRIVACY AND SECURITY PROVISIONS OF
HEALTH-E IT ACT OF 2008 (Comm. Print 2008), available at http://www.house.gov/
stark/news/110th/legislation/200809-HIT/privacy.pdf.
129. CARL H. COLEMAN ET AL., THE ETHICS AND REGULATION OF RESEARCH WITH
HUMAN SUBJECTS 446–47 (2005) (discussing state medical confidentiality laws); see, e.g.,
N.Y. PUB. HEALTH LAW § 17 (McKinney 2002) (prohibiting disclosure of a minor’s medical records concerning abortion and sexually transmitted diseases without the minor’s consent); 71 PA. CONS. STAT. ANN. § 1690.108 (West 1990) (prohibiting disclosure of records
prepared during drug and alcohol abuse treatment); see also Health Privacy — State Law,
http://www.healthprivacy.org/info-url_nocat2304/info-url_nocat_search.htm (last visited
Dec. 19, 2008) (summarizing and providing links to the health information privacy laws of
each state).
130. Terry & Francis, supra note 11, at 709–10 (discussing how state laws can present
challenges for a national EHR system); NCVHS, supra note 114, at 9 (describing the confusion, difficulty, and expense of designing a national health information network to comply
with numerous health privacy laws enacted by the states).
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a month per doctor for maintenance.131 According to a study of Pennsylvania hospitals, the median capital spending per bed for HIT in
2006 was $6912, while the median HIT operating cost per bed was
$14,528.132 The cost of achieving a fully interoperable NHIN has been
estimated at $156 billion in capital investment and $48 billion in yearly operating expenses over five years.133
Transitioning to an EHR system can also place significant administrative burdens upon health care providers. The potential difficulties
of EHR implementation include all of the following: (1) office systems must be redesigned; (2) users must adopt uniform ways of recording data to fit system requirements and must forego their own
shorthand and terminology; (3) data from paper records must be entered into the electronic system; (4) all staff members must learn to be
proficient with the system, and their training takes time away from
patient care; and (5) patients may be concerned about providers
spending considerable time inputting data into computers during examinations, leaving less time for human interaction between the clinician and the individual being examined.134
Even in the long term, use of EHR systems may be time consuming for providers.135 Typing may take physicians longer than dictating
notes.136 One study found that, during consultation, use of EHRs increased the time that doctors spent on activities other than interacting
with patients by as much as twenty-eight percent and that this did not
change with improved computer proficiency.137 Other writers have
noted that, in the intensive care unit, where numerous interventions
131. Thomas Goetz, Editorial, Physician, Upgrade Thyself, N.Y. TIMES, May 30, 2007, at
A21; see also Baron et al., supra note 70, at 223–24 (reporting that an EHR system cost a
four-person medical practice $140,000, including hardware, software, training, and one year
of support, and estimating the system’s annual maintenance cost, including support services,
to be $40,000).
132. HOSP. & HEALTHSYSTEM ASS’N PA., IMPROVING PATIENT CARE: PENNSYLVANIA
HOSPITALS’ USE OF INFORMATION TECHNOLOGY 4 (2007), available at
http://www.haponline.org/downloads/Improving_Patient_Care_PA_Hospitals_Use_of_IT_
HAP_082007.pdf. Capital costs include buildings, medical equipment, and EHR systems,
while operating costs include the daily expenses of running a hospital. Id.
133. Rainu Kaushal et al., The Costs of a National Health Information Network,
143 ANNALS INTERNAL MED. 165, 170 (2005).
134. See, e.g., Baron et al., supra note 70, at 223–24 (describing the difficulties one practice faced in implementing a new EHR system); Connolly, supra note 64 (relating that Cedars-Sinai Medical Center in Los Angeles abandoned its $34 million EHR system after staff
members found that it was “clunky and slow” and that they could not operate it effectively,
because they had received insufficient training); Terry, supra note 111 (describing difficulties associated with EHR implementation).
135. Yong Y. Han et al., Unexpected Increased Mortality After Implementation of a
Commercially Sold Computerized Physician Order Entry System, 116 PEDIATRICS 1506,
1510 (2005) (asserting that CPOE systems require more time for order entry than written
forms, although this may be mitigated by improved overall efficiency).
136. See Baron et al., supra note 70, at 223–24 (discussing increases in patient waiting
times due to the adoption of an EHR system).
137. Mitchell & Sullivan, supra note 62, at 281.
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must be performed in rapid succession, CPOE systems may increase
mortality because staff members must spend significant time at computer terminals rather than at the bedside.138 How time consuming and
problematic an EHR system is, however, depends largely upon its
user interface design.139 Enhanced designs, including mechanisms
such as voice recognition software, allow users to operate systems
more quickly and more safely.140
4. Legal Issues
Use of EHR systems may raise important tort litigation questions.141 Addressing all of the issues in detail is beyond the scope of
this Article, but some bear mentioning. For example, to what extent
will a physician’s reliance on guidance provided through decision
support mechanisms insulate her from liability? Will EHR system
vendors be included as a matter of course in every lawsuit because the
provider’s system might possibly have contributed to the alleged injury?142 If so, will concern about litigation impede NHIN implementation, or will vendors demand immunity?143 Will frequent attempts to
prove failures in complex EHR systems through the testimony of costly expert witnesses drive the costs of litigation and malpractice insurance dramatically higher?
Furthermore, a patient harmed by a malfunction or security vulnerability of an EHR system may face difficulties proving her claims.
The patient may find it very hard to establish that the system was responsible for her injuries unless the inputs provided to the system, the
actions taken by users, and the outputs and actions generated by the
system are faithfully recorded in a form that can be understood by an
expert. It can be extremely challenging to inspect a complex EHR
system’s program code for the defect that was responsible for a failure
138. See, e.g., Han et al., supra note 135, at 1510.
139. See Michael E. Wiklund, Making Medical Device Interfaces More User-Friendly, in
DESIGNING USABILITY INTO MEDICAL PRODUCTS 151–60 (Michael E. Wiklund & Stephen
B. Wilcox eds., 2005) (discussing user-interface problems and techniques for enhancing the
user-friendliness of medical device interfaces).
140. See id.; Ken Terry, Voice Recognition Moves Up a Notch: When the Computer Can
Type While You Talk, You Save Money and Time, MED. ECON., Feb. 20, 2004, at TCP11,
available
at
http://www.memag.com/memag/Technology:+The+Connected+Physician/Voicerecognition-moves-up-a-notch/ArticleStandard/Article/detail/108559.
141. See, e.g., Burton et al., supra note 43, at 465–66 (discussing the uncertainties regarding legal liability of physicians relying on data from other providers).
142. See Arnold J. Rosoff, On Being a Physician in the Electronic Age: Peering into the
Mists at Point-&-Click Medicine, 46 ST. LOUIS U. L.J. 111, 124–28 (2002) (discussing
liability of developers of clinical decision-support software and justifiable reliance by physicians).
143. See ROBERT WOOD JOHNSON FOUND. ET AL., supra note 22, at 45 (noting that “immunity from suit is extremely rare” and that it is possible that HIT will generate new
sources of liability).
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that harmed a patient. Such a defect might involve only one line of
code among many thousands.
Discovery issues might be particularly copious. For example, will
printouts of EHRs accurately reflect the providers’ activities? Will
fragmented screen displays, physician shortcuts, and system inflexibilities impede discovery and distort the medical record?144 Will
EHRs record all of the providers’ activities accurately, comprehensively, and chronologically, or will files be disjointed, confusing, and
incomplete? Will e-mail messages exchanged between patients and
physicians be captured by the EHR system and become part of the
medical record?145
On the other hand, EHRs could significantly facilitate discovery
of the truth in litigation. If all medical interventions are faithfully recorded in EHRs, computerized records will be much more comprehensive than paper files built upon dictation of physicians’ summary
notes. EHR systems could also ease the burdens of discovery by allowing for electronic searches of medical files.146 Both plaintiffs and
defendants could use EHRs to their advantage in litigation.147

III. THE ROLE OF THE LAW AND ADMINISTRATIVE
REGULATION
A. Why Are Legal Interventions Necessary?
EHR systems are not currently regulated by any governmental entity despite being crucial to the effective management of patient care
in practices that use them.148 There are at least two important reasons
for governmental involvement in the realm of EHR systems. First,
EHR systems are unlikely to be widely adopted in the near future
without governmental intervention. The government should require all
health care providers to adopt EHR systems and offer financial support to offset the providers’ costs. Second, individual patients’ lives
and public health will depend on the proper functioning of EHR sys-

144. See supra notes 102–13 and accompanying text (discussing the potential for errors
generated by EHR systems).
145. See ROBERT WOOD JOHNSON FOUND. ET AL., supra note 22, at 45 (“To the extent
that electronic technology makes the meaning of a medical record ambiguous, the scope of
discovery could extend beyond the limits now imposed in paper medical record cases.”).
146. See FED. R. CIV. P. 26(b)(2) advisory committee’s note to 2006 amendments (“Electronic storage systems often make it easier to locate and retrieve information.”).
147. See infra Part IV.C.3 (discussing audit trails and capture/replay and their potential
role in litigation).
148. See Jason Miller, FDA to Propose Rule on E-Health Records, GOV’T HEALTH IT,
June 5, 2007, http://www.govhealthit.com/online/news/102901-1.html (quoting Tim Stitely,
the FDA’s chief information officer, as stating that the FDA does not have jurisdiction to
regulate EHRs and that he is uncertain as to which agency will regulate them).
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tems; therefore, like other goods and services that impact public welfare, EHR systems must be regulated.
1. Financial Support for Universal EHR System Adoption
Although many believe that EHR systems can dramatically improve the quality of health care in the U.S.,149 the majority of health
care providers have failed to adopt EHR systems thus far. According
to a recent national survey, as of early 2008, only 4% of U.S. physicians in ambulatory care settings had fully functional EHR systems,
and 13% had basic systems.150 A fall 2006 survey by the American
Hospital Association concluded that 11% of hospitals had fully implemented EHRs, while 57% had partially implemented EHRs.151 The
survey also found that physicians in only 10% of hospitals routinely
used CPOE at least half of the time.152 A 2006 study of community
health centers showed that 26% asserted that they had some EHR capacity, and those serving largely poor and uninsured patients were
unlikely to have any EHR capabilities.153
Commentators have, in fact, noted a misalignment of incentives.
While providers must invest heavily in the purchase and maintenance
of EHR systems, it is insurers and self-insured employers who will
reap many of the systems’ economic benefits: less frequent duplication of diagnostic tests and fewer medical errors that lead to costly
complications.154
One way to compel the adoption of EHR systems is to establish a
legal mandate requiring their use by all health care providers. We recommend that federal law include such a requirement, which should be
phased in over a period of years, with longer deadlines for smaller
practices.155 Health care providers should be required to purchase and
149. See supra Part II.B (discussing the benefits of EHR systems).
150. DesRoches et al., supra note 6, at 54.
151. AM. HOSP. ASS’N, supra note 6, at 3, 5. Survey responses were received from over
1,500 community hospitals, which constitute approximately one-third of all community
hospitals in the U.S. Id. at 1. The survey also found that forty-six percent of community
hospitals made moderate or high use of HIT, including medication order entry, test result
review, and clinical alert mechanisms, and that fifty-one percent of hospitals used real-time
drug interaction alerts. Id.
152. Id. at 5.
153. Shields et al., supra note 72, at 1376. The survey also found that “only 13 percent
[of community health centers] have the minimum set of functionalities defined by the national HIT Adoption Initiative.” Id.
154. See David F. Doolan & David W. Bates, Computerized Physician Order Entry Systems in Hospitals: Mandates and Incentives, 21 HEALTH AFF. 180, 183–84 (2002) (discussing lack of financial incentives for provider implementation of EHR systems); Blackford
Middleton et al., Accelerating U.S. EHR Adoption: How to Get There from Here. Recommendations Based on the 2004 ACMI Retreat, 12 J. AM. MED. INFORMATICS ASS’N 13, 14
(2005) (discussing “misaligned incentives”).
155. Cf. HIPAA Privacy Regulations, 45 C.F.R. §§ 164.318 & 164.534 (2007) (providing
different compliance deadlines for various types of covered entities).
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maintain EHR systems and also to make good faith use of their various components, including decision support, CPOE, and other capabilities. Federal regulations, consequently, should provide specific
instructions as to what constitutes acceptable use.
Nevertheless, we also recognize that the imposition of such a
mandate would be unjust without financial support for those who
must bear the expense of fulfilling it. The federal government has already recognized the problem and begun addressing it through several
initiatives. On August 1, 2006, the Centers for Medicare & Medicaid
Services (“CMS”) and the Office of the Inspector General adopted
final regulations that create exceptions and safe harbors to federal
fraud and abuse laws in order to encourage the donation of EHR systems.156 The regulations establish the conditions under which entities
may donate interoperable EHR and electronic prescribing hardware,
software, information technology, and training without violating the
physician self-referral law157 and the federal anti-kickback statute.158
The Internal Revenue Service has also recently issued a memo in
which it established that nonprofit hospitals can provide EHR systems
and support services to staff physicians without compromising their
tax-exempt status.159
In addition, several congressional bills have been designed to offer various incentives to health care providers for the adoption of EHR
systems. The proposed Wired for Health Care Quality Act of 2007
would provide $139 million in fiscal years 2008 and 2009, as well as
further funding in subsequent years for HIT-related grants and loans
to health care providers and to states.160 Likewise, the Health-e Information Technology Act of 2008 proposes incentive payments of up to
$40,000 over five years to physicians and several million dollars to
hospitals for HIT adoption.161 While such incentive programs may

156. 42 C.F.R. § 411.357(v)-(w) (2007); 42 C.F.R. § 1001.952(x)-(y) (2007); see Press
Release, U.S. Dep’t of Health & Human Servs., New Regulations to Facilitate Adoption of
Health Information Technology (Aug. 1, 2006), available at http://www.hhs.gov/news/
press/2006pres/20060801.html.
157. See 42 U.S.C. § 1395nn (2000 & Supp. V 2005), amended by Medicare Improvements for Patients and Providers Act of 2008, Pub. L. No. 110-275, 122 Stat. 2494.
158. See 41 U.S.C. §§ 51–58 (2000).
159. Memorandum from Lois G. Lerner, Exempt Organizations Director, Internal Revenue Service, Hospitals Providing Financial Assistance to Staff Physicians Involving Electronic Health Records (May 11, 2007), available at http://www.irs.gov/pub/irs-tege/
ehrdirective.pdf.
160. Wired for Health Care Quality Act, S. 1693, 110th Cong. §§ 3008(a)(1), (b)(1),
(e)(1) (2007); see Senate HELP Committee Approves Health IT Legislation by Voice Vote,
15 BNA’S HEALTH CARE POL’Y REP. 873 (2007) (reporting that the Senate Health, Education, Labor, and Pensions Committee approved the proposed legislation on June 27, 2007).
161. Health-e Information Technology Act, H.R. 6898, 110th Cong. §§ 301–302 (2008).
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effectively encourage EHR system use, none of the proposed bills has
passed thus far.162
2. The Need for Quality Control
The federal government must regulate EHR systems because their
dependability and usability are crucial to patient welfare. A defect in
the software of an EHR system containing hundreds or thousands of
medical records, such as a flaw that causes inaccurate recording of
patients’ allergies or medications, could adversely affect a very large
number of patients. The risk is amplified by the fact that EHR system
functionality extends well beyond simple record keeping. Through
features such as decision support and order entry, EHR systems already significantly influence the course of patients’ treatments. Moreover, it is possible that, before long, the analytical power of these
systems will increase so much that they will assume a key role in
medical diagnosis and treatment management.
The potentially devastating effect of system malfunctions is illustrated by the following incident. A hospital pharmacy’s computer
program generated erroneous medication order lists, leading to the
delivery of the wrong drugs to patients in the wards.163 Had the hospital staff not been vigilant and detected the mistakes, the consequences
could have been catastrophic for some patients.164
A website entitled Bad Health Informatics Can Kill provides various examples of instances in which CPOE led to serious errors as
well as other illustrations of how medical mistakes have been caused
by technology, though not necessarily through EHR systems.165 In
truth, there is no way to know how many malfunctions have actually
occurred because EHR systems are not subject to a governmentally
mandated adverse-event-reporting requirement, unlike FDA-regulated
drugs and devices.166
As noted earlier, the federal government has in fact begun to regulate electronic health information in the areas of privacy and security. HHS has enacted the HIPAA Privacy and Security Rules, under
162. Business Leaders, Senators Urge Action on Health IT Bill, Despite Privacy Concerns, 16 BNA’S HEALTH CARE POL’Y REP. 457 (2008); Jeff Day, Legislation to Advance
EMR Adoption Unlikely to Move Before Mid-2009, Aide Says, 16 BNA’S HEALTH CARE
POL’Y REP. 1475 (2008) (explaining that “Congress is unlikely to take action on federal
legislation that would pay doctors to adopt electronic medical record systems until well into
2009” because it will need to focus instead “on the economic crisis, the wars in Afghanistan
and Iraq, and on passing fiscal year 2009 appropriations bills.”).
163. Cook & O’Connor, supra note 17, at 80–82 (explaining that the problem was rooted
in a backup tape that was incomplete and corrupted).
164. Id.
165. EFMI-WG Assessment of Health Information Systems, Bad Health Informatics Can
Kill, http://iig.umit.at/efmi/badinformatics.htm (last visited Dec. 19, 2008).
166. See 21 C.F.R. § 803 (2007) (discussing FDA adverse event reporting requirements).
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which a variety of requirements have been established for the use,
disclosure, and protection of health information.167 If the government
is to protect patients’ privacy through regulation of HIT, then surely it
should also safeguard patients’ health and safety by regulating the
quality of EHR systems.
The federal government routinely regulates goods and services
that impact public health and welfare. For example, the Department of
Transportation regulates pipeline and hazardous material transport,
railroads, motor carriers, cargo containers, highway traffic, and other
transportation matters.168 The Federal Aviation Administration
(“FAA”) regulates air traffic, air carriers, aircraft manufacturers,
crewmembers, pilot schools, airports, and navigational facilities.169
Most relevant is the FDA’s extensive regulation of drugs, devices,
and biologics.170 The term “device” is statutorily defined in relevant
part as: “an instrument, apparatus, implement, machine . . . which
is . . . intended for use in the diagnosis of disease or other conditions,
or in the cure, mitigation, treatment, or prevention of disease.”171 Given that they feature decision support, order entry, and other care delivery and management functions, one might reasonably conclude that
EHR systems are as essential to patient care as are many regulated
devices.172 Furthermore, their software can be more complicated than
that found in many computer-controlled medical devices that are subject to FDA jurisdiction.173
Free market advocates might argue that EHR systems should remain unregulated because competitive market forces can safeguard
their quality, as low-quality products will fail in the marketplace. This
argument, however, is not persuasive for several reasons.174
First, government regulation is necessary to prevent market failure due to lack of information available to potential consumers. The
167. HIPAA Privacy Rule, 45 C.F.R. §§ 160.101–164.534 (2007); HIPAA Security Rule,
45 C.F.R. §§ 164.302–.318 (2007); see Hoffman & Podgurski, supra note 115; Hoffman &
Podgurski, supra note 121; supra notes 115 and 121 and accompanying text (critiquing the
Privacy and Security Rules).
168. See 49 C.F.R. §§ 1–1572.405 (2007) (transportation regulations).
169. See 14 C.F.R. §§ 1–198.17 (2007) (FAA regulations).
170. See 21 C.F.R. § 7.3(f) (2007) (defining “product” as “an article subject to the jurisdiction of the Food and Drug Administration, including any food, drug, and device intended
for human or animal use [or] any cosmetics and biologic intended for human use”). See
generally 21 C.F.R. §§ 1–1405.670 (2007) (food and drug regulations).
171. 21 U.S.C. § 321(h) (2006).
172. See INST. OF MED., supra note 2, at 5 (noting that it is important to recognize the
many uses of EHR systems, including care delivery, management, and support processes).
173. See Nayar & Miller, supra note 112, at 49 (discussing the complexity of EHR systems).
174. Cf. CHARLES P. FRIEDMAN & JEREMY C. WYATT, EVALUATION METHODS IN
BIOMEDICAL INFORMATICS 357 (2d ed. 2006) (“[W]hile having been an entirely unregulated
market in the past, the efficacy and safety of clinical information systems are increasingly
attracting attention, creating new challenges, opportunities, and requirements for evaluation.”).
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market cannot weed out low-quality products if consumers are not
informed about the relative quality of the various products available.
Without a governmentally mandated adverse event reporting requirement, the public may never find out which products are defective or
inferior to others, and thus they will be unable to make educated purchasing decisions. Vendors have little incentive to disclose product
flaws to the public voluntarily. Complaints posted on Internet sites or
blogs can be unreliable or technically imprecise and, therefore, may
not be a trustworthy source for consumer advocacy groups interested
in developing consumer reports. Health care providers who use EHR
systems may hesitate to disclose adverse events suffered by patients
that are associated with EHR systems because of the HIPAA Privacy
Rule175 or because of fear of lawsuits by vendors. In addition, even if
users were inclined to report system defects to publicly available
sources, they might still be slow to recognize emergent software problems because of their subtlety or complexity, and they may fail to understand their significance.176 Consequently, absent a carefully
regulated approval process conducted by experts, many providers
might purchase a new EHR system before its defects were widely
known.
Second, market forces may be further thwarted by the fact that
providers who have already invested in and implemented a faulty
EHR system cannot readily take their business elsewhere. Once a provider has adopted an EHR system, it will be disinclined to switch to a
new system, even if its current system is faulty. Such a switch could
be prohibitively expensive and burdensome, as it would require transferring all existing patient records to a different product and training
all staff members to adjust to the new product’s peculiarities.
Third, while the threat of litigation might normally discourage
sloppy software engineering, in the realm of complex HIT, liability
might be so difficult to prove that vendors will believe they bear little
risk of costly judgments or even of plaintiffs initiating suit.177 Plaintiffs’ attorneys will realize that they cannot prevail without well qualified experts who invest considerable time in studying the EHR system
at issue. Therefore, lawyers may refuse to represent all but the wealthiest clients who can finance the retention of such experts without
175. 45 C.F.R. §§ 160.101–164.534 (2007). Clinicians would need to make sure that
whatever information they convey about incidents does not identify particular patients and
cannot be traced to specific individuals. See id. §§ 164.502–.514 (2007) (establishing regulations for the use and disclosure of protected health information).
176. See infra notes 194–95 and accompanying text (discussing the lengthy delays that
can precede the emergence of a problem in a complex software system).
177. See supra Part II.C.4 (discussing proof and discovery problems); infra Part IV.C.3
(discussing recommendations that audit trails and capture/replay be required by regulation
to facilitate detection and proof of system failures); see also infra notes 301–02 and accompanying text (suggesting that the regulatory agency make adverse event reports available to
the public).
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any certainty of recovering the costs through settlement or favorable
judgments.
Finally, market forces alone cannot be trusted to ensure the interoperability of EHR systems, which is essential to the systems’ efficacy. Interoperability would likely be disfavored by vendors because
it could reduce profits and increase costs.178 Although the earliest
electronic hospital information systems emerged in the late 1960s,179
interoperability has yet to be achieved, and no product has come close
to gaining a monopoly that would eliminate the need for interoperability among competing products.180 Furthermore, both the practice of
customizing products to accommodate providers’ preferences and the
inherent complexity of representing medical information constitute
potential obstacles to interoperability.181 This important capacity will
likely be achieved only through regulatory mandates.
3. The Current Oversight System: CCHIT
To its credit, the HIT industry has engaged in an effort to selfregulate, particularly through the Certification Commission for
Healthcare Information Technology (“CCHIT”).182 However, this
initiative falls far short of providing comprehensive oversight for
EHR systems. CCHIT, a private-sector organization, was created in
2004 and is composed of three HIT industry associations: the American Health Information Management Association; the Healthcare Information and Management Systems Society; and the National
Alliance for Health Information Technology.183 HHS awarded CCHIT
a three-year contract in September 2005 with a mandate to develop
certification criteria and an inspection procedure for EHR systems in
the areas of office-based ambulatory care, inpatient care, and interoperability.184 CCHIT has certified over fifty ambulatory care EHR systems and a dozen inpatient systems under its 2007 criteria.185
178. See infra notes 332–32 and accompanying text (discussing financial incentives
working against the adoption of interoperable EHR systems).
179. BIOMEDICAL INFORMATICS, supra note 1, at 451.
180. See infra note 185 and accompanying text (discussing the numerous EHR products
certified for use by providers). In the word-processing area, Microsoft’s Word has nearly
achieved such a monopoly.
181. See infra notes 327–27 and accompanying text.
182. CCHIT: Certification Commission for Healthcare Information Technology,
http://www.cchit.org/about/ index.asp (last visited Dec. 19, 2008).
183. FAQ Frequently Asked Questions — CCHIT Certification Commission for Healthcare
Information
Technology,
http://www.cchit.org/about/faq/
general.asp#founding (last visited Dec. 19, 2008).
184. CCHIT, CERTIFICATION HANDBOOK 60 (2008) [hereinafter CERTIFICATION
HANDBOOK],
available
at
http://www.cchit.org/files/certification/08/Forms/
CCHITCertified08Handbook.pdf.
185. See CCHIT, CCHIT Certified Ambulatory EHR 2007, http://www.cchit.org/choose/
ambulatory/2007/index.asp (last visited Dec. 19, 2008); CCHIT Certified Inpatient EHR
2007, http://www.cchit.org/choose/inpatient/2007/index.asp (last visited Dec. 19, 2008).
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Applicants must pay CCHIT for certification,186 and ambulatory care
products are certified for a period of two years,187 during which
CCHIT monitors product changes188 and requires recertification for
products that have been significantly modified.189
CCHIT, however, is an industry-run organization, and its certification criteria are vulnerable to criticism as being excessively favorable to vendors. There are several areas of concern. First, prior to
product testing, applicants are able to access the criteria, testing scenarios, and test scripts on CCHIT’s website.190 Vendors, therefore,
need not be prepared for unanticipated tests that might reveal flaws in
the system that they did not encounter in practicing the testing scenarios. Second, all testing for clinical functionality, interoperability, and
security occurs during one day.191 Consequently, inspectors do not
observe the system operating over time and in a variety of usage environments. Third, the certification jury is composed of “three clinical
experts, at least one of whom must be a practicing physician.”192
However, jurors cannot confer or deliberate during the demonstration
or voting process,193 so they cannot draw each others’ attention to
concerns or product shortcomings.
CCHIT’s single day of testing is particularly troubling because
experience indicates that it is unlikely to detect many significant reliability and safety problems. Though there are many examples, a series
of incidents involving the Therac-25 radiation therapy machine vividly illustrates this point.. Between 1985 and 1987 six patients died of
massive radiation overdoses caused by software defects.194 The machine had passed safety analysis in 1983, which did not include software testing, and it was not recalled until after the sixth incident in
1987.195 Likewise, flaws in EHR systems may not be initially obvious
but could cause life-threatening errors after a period of time. Such
errors could include deleting or incorrectly recording information
about patient allergies, lists of medications already prescribed to a
patient, or electronic medication orders. Patients who receive incor-

186. See CERTIFICATION HANDBOOK, supra note 184, at 66–67.
187. Id. at 45 (“The term for Ambulatory EHR Certification, as it relates to a specific
product version, will be two (2) years from the Certification Date . . . .”).
188. See id. at 44 (detailing penalties for discrepancies between the certified product and
the product that a company is actually marketing).
189. See id. at 47–49 (describing CCHIT policies and procedures pertaining to product
modifications).
190. Id. at 15 (urging applicants to prepare for their inspection date by reviewing the material carefully and practicing their demonstration of the test scripts).
191. See id. at 25–27 (describing durations of testing procedures).
192. Id. at 28.
193. Id. at 29.
194. Nancy G. Leveson, & Clark S. Turner, An Investigation of the Therac-25 Accidents,
26 IEEE COMPUTER 18, 21 (1993).
195. Id. at 20–21.
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rect medications or drug dosages may well suffer serious or fatal
harm.
CCHIT published final 2008 criteria for ambulatory care EHR
products.196 These documents are substantial and cover many important areas. However, they also leave significant gaps. For example,
they do not specify requirements concerning the reliability197 or
safety198 of EHR systems.199
CCHIT, in fact, recognizes some of its own limitations. Its Certification Handbook states:
[O]ur criteria at this point can only represent broad,
basic capabilities, and . . . these may prove insufficient for some practice specialties, or may be inappropriate or excessive for others; . . . our criteria do
not assess product usability, implementation service,
product maintenance, technical and application support; and other facts.200
Admittedly, EHR systems could be required to have almost endless
capabilities. Determination of which capabilities should be required
will necessitate careful deliberation and input from many interested
parties, including physicians, patient representatives, public interest
groups, and academic researchers.
B. Who Should Regulate?
If EHR systems are to be regulated, their regulation must be assigned to a particular agency. This Section considers several options.
While the FDA might initially seem to be the appropriate regulatory
agency, it is not the optimal choice, for reasons elaborated below. The
Centers for Medicare & Medicaid Services (“CMS”) would be a bet-

196. CCHIT, AMBULATORY CERTIFICATION CRITERIA — FINAL CRITERIA (2008),
http://www.cchit.org/certify/ambulatory/index.asp.
197. The reliability of a system is the probability that it will correctly deliver services
over a given interval of use. IAN SOMMERVILLE, SOFTWARE ENGINEERING 48 (8th ed.
2007).
198. A system’s safety is “a judgment of how likely it is that the system will cause damage to people or its environment.” Id.
199

This is true despite the fact that Section 5.6 of the CCHIT 2008 Certification Handbook
indicates that the following is an approved description of the CCHIT certification program:
The Certification Commission for Healthcare Information Technology’s
(CCHIT®)” inspection process is based on real-life medical scenarios designed
to test products rigorously against the clinical documentation needs of providers
and the quality and safety needs of healthcare consumers and payers.
CCHIT, supra note 196.
200. CERTIFICATION HANDBOOK, supra note 184, at 40.
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ter alternative, as would a newly created agency tasked with oversight
of health information technology in the U.S.
1. FDA Jurisdiction
As noted above, the FDA thus far has not taken the initiative to
regulate EHR systems.201 The FDA’s authority to regulate devices
extends to computer software that is “integral to . . . or closely connected with” any apparatus that delivers patient care, such as a CAT
scanner or a respirator.202 However, its authority to regulate EHR systems is much more dubious.
In 1989 draft guidance, the FDA declined to extend its regulatory
authority to software that is “intended for use only in traditional ‘library’ functions, such as storage, retrieval, and dissemination of medical information — functions traditionally carried out through
textbooks or journals.”203 The FDA also exempted software with
“general accounting or communication” and educational functions.204
Of particular significance is the draft policy’s exemption of computer
products, such as decision support systems, that involve “competent
human intervention before any impact on human health occurs.”205
EHR systems serve library, accounting, and communication functions.
Furthermore, unlike pacemakers or respirators that operate independently once they are connected to the body, EHR systems have no impact without human input and intervention. Consequently, they would
appear to be excluded from active FDA regulation under this policy.
In a 1996 workshop, the FDA recognized the difficulties of determining what constitutes “competent human intervention,” which in
turn determines whether medical software should be regulated by the
agency.206 With respect to decision support, “competent human intervention” requires that users have the time, motivation, and ability to
reflect upon and challenge computer-generated data and recommendations, which may not be true in the midst of surgery or in the intensive
care unit.207 In addition, medical software is often so complicated that
201. See Miller, supra note 148.
202. See Rosoff, supra note 142, at 121.
203. CTR. FOR DEVICES & RADIOLOGICAL HEALTH, FDA, FDA POLICY FOR THE
REGULATION OF COMPUTER PRODUCTS 1 (proposed 1989) [hereinafter 1989 DRAFT FDA
POLICY], available at http://www.fda.gov/cdrh/ode/351.pdf. The policy was never formally
adopted, but the draft policy informed the FDA’s approach to stand-alone software systems
throughout the 1990s. See Randolph A. Miller & Reed M. Gardner, Recommendations for
Responsible Monitoring and Regulation of Clinical Software Systems, 4 J. AM. MED.
INFORMATICS ASS’N 442, 445–46 (1997).
204. 1989 DRAFT FDA POLICY, supra note 203, at 1.
205. Id. at 3.
206. FDA & Nat’l Library Med., Software Policy Workshop (Sept. 3–4, 1996) (unpublished workshop handouts), available at http://www.netreach.net/~wmanning/
fdaswsem.htm#background.
207. Id.
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users cannot analyze or understand its computations and, therefore,
cannot exercise competent human intervention.208 EHR system complexity, in fact, is likely to increase as more sophisticated functions,
such as diagnostic algorithms based on machine learning,209 are incorporated. Doctors who rely excessively on computer-generated diagnoses and treatment recommendations may fail to perceive that the
algorithms did not account for certain conditions that are pertinent to
their patients. By the same token, some doctors may unreasonably
mistrust EHR system decision support, choosing to follow their intuition, rather than computerized recommendations, to the detriment of
their patients. Consequently, “competent human intervention” cannot
protect adequately against potentially harmful software defects, since
most clinicians will not be able to determine whether these sophisticated tools have formulated the correct approach in a particular instance. The 1996 workshop called for reexamination of the FDA’s
criteria for regulatory exemptions relating to software,210 an initiative
that has not been pursued to date.
One option for regulating EHR systems is to include them explicitly within the FDA’s jurisdiction. The FDA might effect such an extension of its jurisdiction by explicitly adopting an interpretive rule
that reconstrues its statutory authority over devices to include EHR
systems. However, the courts have resisted past efforts by the FDA to
expand its authority to cover an area that it has not traditionally regulated. For example, in FDA v. Brown & Williamson Tobacco Corp.,
the Supreme Court concluded that the Food, Drug, and Cosmetic Act
(“FDCA”) did not grant the FDA jurisdiction over tobacco products.211 When it comes to EHR systems, the HIT industry, like the
tobacco industry, could oppose FDA regulatory authority and turn to
the courts for relief. Consequently, the extension of the FDA’s authority to EHR systems may require a revision of the FDCA’s definition
of “device”212 to make clear that EHR systems are covered. Statutory
amendments, however, are often hindered by special interest lobbying
and political, rather than public policy, concerns.213

208. Id.
209. “Machine learning” refers to a machine’s ability to learn to perform tasks through
examples or analogies to similar, previously-executed tasks and to improve performance
based on past experience. Jaime G. Carbonell et al., An Overview of Machine Learning, in
MACHINE LEARNING: AN ARTIFICIAL INTELLIGENCE APPROACH 4 (Ryszard S. Cichalski et
al. eds., 1985); TOM M. MITCHELL, MACHINE LEARNING 1 (1997).
210. FDA & Nat’l Library Med., supra note 206.
211. 529 U.S. 120, 159–60 (2000).
212. For the current definition, see 21 U.S.C.A. § 321(h) (West 1999 & Supp. 2008).
213. See ANTONIN SCALIA, A MATTER OF INTERPRETATION 34–35 (1997) (discussing the
role of lobbyists and arguing that, because of their involvement, legislative history is not an
appropriate tool for statutory interpretation); Joseph Tussman & Jacobus tenBroek, The
Equal Protection of the Laws, 37 CAL. L. REV. 341, 350 (1949) (“Everything that emerges
from the legislative forum is tainted by its journey through the lobby.”).
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Even if the FDA had jurisdiction over EHR systems, regulation
by this agency may not be the optimal approach. The regulatory
framework that the FDA is likely to apply to EHR systems would be
inadequate for these patient management tools.
The FDA classifies devices into three categories based on the level of oversight deemed necessary to assure their safety and efficacy.214
“Class I devices” do not sustain, support, or protect human life or
health and do not present an unreasonable risk of human illness or
injury.215 These devices are subject only to the FDA’s “general controls,” such as those relating to misbranding or adulteration.216 “Class
II devices” are used to support or sustain human life but do not pose
the highest risk of injury. Such devices are subject to additional “special controls” at the discretion of the Secretary of HHS.217 “Class III
devices” sustain, support, or protect human life or health or present an
unreasonable risk of causing human illness or injury.218 Class III devices are subject to all of the above controls as well as to premarket
approval (“PMA”) by the FDA.219
The FDA, however, allows manufacturers to avoid the PMA
process by showing that their new device is “substantially equivalent”220 to a legally marketed predicate device.221 In order to obtain a
finding of substantial equivalence, applicants can submit what is
known as a “510(k) application.”222 The FDA will grant a PMA exemption if it determines that the device at issue has the same intended
use as the predicate device and the same technological characteristics
or that the device is demonstrably as safe and effective as an already
marketed device.223 Furthermore, the HHS Secretary is statutorily
required to design information requests so that they are minimally

214. 21 U.S.C.A. § 360c (West 1999 & Supp. 2008); see A PRACTICAL GUIDE TO FOOD
R. Piña & Wayne L. Pines eds., 2d ed.

AND DRUG LAW AND REGULATION 127–30 (Kenneth
2002) [hereinafter A PRACTICAL GUIDE].

215. 21 U.S.C.A. § 360c(a)(1)(A).
216. A PRACTICAL GUIDE, supra note 214, at 128.
217. 21 U.S.C.A. § 360c(a)(1)(B).
218. Id. § 360c(a)(1)(C).
219. Id.
220. Id. § 360c(i).
221. Id. § 360c(f)(1); Benjamin A. Goldberger, The Evolution of Substantial Equivalence
in FDA’s Premarket Review of Medical Devices, 56 FOOD & DRUG L.J. 317, 318, 325–27
(2001) (discussing substantial equivalence).
222. Goldberger, supra note 221, at 318. The 510(k) application is named after the
FDCA section that originally authorized the process, now codified at 21 U.S.C.
§ 360c(f)(1)(A). Eric Chan, Comment, The Food and Drug Administration and the Future
of the Brain-Computer Interface: Adapting FDA Device Law to the Challenges of HumanMachine Enhancement, 25 J. MARSHALL J. COMPUTER & INFO. L. 117, 142 n.152 (2007).
223. 21 U.S.C.A. §§ 360c(f)(1), 360c(i)(1)(A).
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burdensome to 510(k) applicants.224 Accordingly, the FDA requires
clinical data for only a minority of 510(k) reviews.225
The 510(k) process has become so popular with manufacturers
who wish to avoid the more onerous and lengthy PMA procedure that
over seventy-five percent of medical devices are approved through
this process.226 The 2004 Center for Devices and Radiological Health
(“CDRH”) annual report shows a consistent ten-to-one ratio of approved 510(k) applications to approved PMA applications from fiscal
years 1999 through 2004.227 Moreover, according to one source that
reviewed 510(k) applications in the early 1990s, CDRH generally
rejected only two percent of the applications.228
In light of this approval framework, it is unlikely that EHR systems would receive adequate scrutiny by the FDA. First, because
EHR systems do not directly sustain, support, or protect human life or
health, they may well be deemed Class I devices, which receive minimal oversight. Second, even if they are categorized as Class III devices, after the FDA approves the first EHR system, subsequent
systems would probably be reviewed under the substantial equivalence standard rather than the more rigorous PMA standard.229 Two
EHR systems produced by different vendors, however, are likely to
have very different programming, and hence their reliability may differ dramatically. Thus, the 510(k) process is ill-suited to the approval
of new EHR systems and should not be the basis of EHR system regulation.
Finally, the FDA is currently a beleaguered entity. The FDA is
subject to budgetary limitations that could constrain its ability to exercise adequate oversight over complicated technological devices.230
The agency has also been heavily criticized for inadequacies in its
approval and monitoring processes and for other shortcomings.231
224. Id. § 360c(i)(1)(D) (“[T]he Secretary shall consider the least burdensome means of
demonstrating substantial equivalence and request information accordingly.”).
225. Goldberger, supra note 221, at 329–30.
226. A PRACTICAL GUIDE, supra note 214, at 134.
227. CTR. FOR DEVICES & RADIOLOGICAL HEALTH, FDA, CDRH FISCAL YEAR 2004
ANNUAL REPORT 28 tbl.2 (2005), available at http://www.fda.gov/cdrh/annual/
fy2004/fy2004.pdf (reporting that, in 2004, the CDRH approved 3,917 new 510(k)s and 39
original PMAs).
228. STAFF OF SUBCOMM. ON OVERSIGHT & INVESTIGATION OF THE H. COMM. ON
ENERGY & COMMERCE, 103D CONG., LESS THAN THE SUM OF ITS PARTS: REFORMS
NEEDED IN THE ORGANIZATION, MANAGEMENT, AND RESOURCES OF THE FDA’S CENTER
FOR DEVICES AND RADIOLOGICAL HEALTH 38 (Comm. Print 1993).
229. See A PRACTICAL GUIDE, supra note 214, at 140–41 (comparing the 510(k) and
PMA procedures).
230. Miller & Gardner, supra note 203, at 453.
231. See, e.g., Russell Korobkin, Who Should Protect the Public? The Supreme Court
and Medical Device Regulation, 357 NEW ENG. J. MED. 1680, 1680 (2007) (“[T]he FDA’s
post-approval monitoring system has been widely considered to be underfunded and hamstrung by the agency’s limited authority.”); Bruce M. Psaty & R. Alta Charo, FDA Responds to Institute of Medicine Drug Safety Recommendations — In Part, 297 JAMA 1917,

No. 1]

Electronic Health Record Systems

37

2. Oversight by the Center for Medicare & Medicaid Services or a
Newly Created Agency
The existing agency that might be best suited to regulate EHR
systems is the Center for Medicare & Medicaid Services (“CMS”).
According to CMS, as of 2002, 79.3 million individuals were CMS
beneficiaries through Medicare, Medicaid, and the State Children’s
Health Insurance Program (“SCHIP”),232 and providers earned approximately thirty-three percent of their revenues from the public programs overseen by CMS.233 Essentially all hospitals and the
overwhelming majority of physicians in the U.S. participate in Medicare, and many participate in Medicaid. Thus, they must follow CMS
mandates.234 CMS has broad regulatory authority and has promulgated numerous federal regulations.235 Consequently, assigning EHR
system oversight to CMS would not subject most providers to regulation by an unfamiliar agency; rather, it would add to the requirements
they must already meet in order to achieve CMS compliance. Furthermore, if enforcement provisions include the threat that violators
would be denied Medicare, SCHIP, or Medicaid reimbursement,
compliance is likely to be high.236
In order to extend CMS jurisdiction to the minority of providers
that do not participate in any federal health care program, Congress
would need to pass enabling legislation that would provide the agency
with authority to regulate all EHR systems with respect to all patients,
1917–19 (2007) (noting that the FDA is underfunded even though the products it regulates
constitute 25% of the U.S. gross domestic product, that it suffers from a lack of transparency, that the agency relies on a “postmarketing surveillance system that could hardly be
weaker,” and that its post-approval enforcement mechanisms are often limited to threats of
bad publicity); Sheila Weiss Smith, Sidelining Safety — The FDA’s Inadequate Response to
the IOM, 357 NEW ENG. J. MED. 960, 961 (2007) (“[T]he very structure of the FDA marginalizes safety.”); Andrew Pollack, New Sense of Caution at F.D.A., N.Y. TIMES, Sept. 29,
2006, at C1 (discussing the “barrage of criticism” aimed at the FDA).
232. CTRS. FOR MEDICARE & MEDICAID SERVS., PROGRAM INFORMATION ON
MEDICARE, MEDICAID, SCHIP AND OTHER PROGRAMS OF THE CENTERS FOR MEDICARE &
MEDICAID SERVICES: CMS PROGRAM OPERATIONS 3 (2002), http://www.cms.hhs.gov/
TheChartSeries/downloads/sec2_z.zip.
233. CTRS. FOR MEDICARE & MEDICAID SERVS., PROGRAM INFORMATION ON
MEDICARE, MEDICAID, SCHIP, AND OTHER PROGRAMS OF THE CENTERS FOR MEDICARE
AND MEDICAID SERVICES: U.S. HEALTH CARE SYSTEM 6 (2002), http://www.cms.hhs.gov/
TheChartSeries/downloads/sec1_z.zip.
234. Timothy Stoltzfus Jost, Racial and Ethnic Disparities in Medicare: What the Department of Health and Human Services and the Centers for Medicare and Medicaid Services Can, and Should, Do, 9 DEPAUL J. HEALTH CARE L. 667, 669 (2005) (describing
Medicare participation); Sidney D. Watson, Health Care in the Inner City: Asking the Right
Question, 71 N.C. L. REV. 1647, 1667 (1993) (stating that most hospitals participate in Medicaid).
235. See, e.g., 42 C.F.R. pts. 400-413. (2007).
236. The HHS Secretary has authority to deny payment to skilled nursing facilities that
have not met particular requirements. 42 U.S.C. § 1395i-3(h)(2)(B)(i) (2000). A similar
penalty could be established for non-compliance with regulatory requirements pertaining to
EHR Systems.
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regardless of their Medicare, Medicaid, or SCHIP status. This approach would not be unprecedented, because CMS already enforces
the HIPAA Security Rule,237 which governs the security of electronic
health information for a broad range of providers, regardless of
whether they participate in Medicare, Medicaid, or SCHIP.238 Furthermore, through its enforcement of the Security Rule, CMS has acquired expertise with respect to HIT.239 Nevertheless, assigning CMS
oversight responsibilities for EHR systems would require increases in
the agency’s human, financial, and other resources.
A second option, which has been suggested by HHS, is to create
an entirely new regulatory agency that will be responsible for the development, implementation, and regulation of EHR systems and the
NHIN.240 Congress has periodically created new agencies to regulate
emerging areas of law. For example, Title VII of the Civil Rights Act
of 1964 established the Equal Employment Opportunity Commission,
which enforces federal employment discrimination laws.241 Under the
Occupational Safety and Health Act of 1970, the Occupational Safety
and Health Administration was established to promote workplace
safety,242 and the Health Care Financing Administration, now the
Centers for Medicare & Medicaid Services, was established in 1977 to
administer the Medicare and Medicaid programs.243 Creation of a new
agency may encounter resistance because it could be costly and would
constitute an expansion of government. However, an adequately
funded agency focused exclusively on HIT, with a concentration of
technical talent and expertise, could be an effective vehicle for regulating EHR systems.

237. 45 C.F.R. §§ 160.302–.316 (2007).
238. See Centers for Medicare & Medicaid Services Statement of Organization, Functions, and Delegation of Authority, 68 Fed. Reg. 60,694, 60,694 (Oct. 23, 2003).
239. The Security Rule establishes administrative, physical, and technical requirements
to safeguard the security of electronic health records. See 45 C.F.R. §§ 160.302–.316
(2007). CMS has authority to investigate and resolve claims of alleged Security Rule violations. 45 C.F.R. §§ 160.306, 160.308 (2007).
240. U.S. DEP’T OF HEALTH & HUMAN SERVS., SUMMARY OF NATIONWIDE HEALTH
INFORMATION NETWORK (NHIN) REQUEST FOR INFORMATION (RFI) RESPONSES 12 (June
2005), http://www.hhs.gov/healthit/rfisummaryreport.pdf (suggesting that the federal government could create a health information agency to govern, finance, and set standards for
the NHIN or could assign these tasks to an existing agency).
241. The Civil Rights Act, 42 U.S.C. § 2000e-4 (2000); see U.S. Equal Employment Opportunity Commission (EEOC), http://www.eeoc.gov.
242. The Occupational Safety and Health Act, 29 U.S.C. §§ 651–78 (2006); see Occupational Safety and Health Administration — OSHA HOME PAGE, http://www.osha.gov.
243. CTRS. FOR MEDICARE & MEDICAID SERVS., KEY MILESTONES IN CMS PROGRAMS
(2006), http://www.cms.hhs.gov/History/Downloads/CMSProgramKeyMilestones.pdf.
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IV. RECOMMENDATIONS FOR A REGULATORY FRAMEWORK
FOR EHR SYSTEMS
This Part develops recommendations for a regulatory framework
to govern EHR systems. First, to achieve universal EHR system adoption, the government will need to provide financial support to resource-poor providers. The proposed regulations also address the
design of approval and monitoring processes for EHR systems, standardization of essential system features and capabilities, and the creation of a national databank of de-identified EHRs. These
recommendations aim to serve as a model that will initiate a discussion about the need for and potential contours of a regulatory scheme
for HIT. They do not seek to perfect all of the details of future regulatory provisions.
A. Addressing the Cost of EHR System Adoption
1. Financial Support
As several legislators and administrative agencies have already
recognized, it is unreasonable to expect widespread adoption of EHR
systems without financial support.244 The transition from paper files to
EHR systems can be expensive, complicated, and burdensome, especially for smaller medical practices.245 Given a regulatory requirement
that all providers adopt EHR systems, the government should offer
financial support in the form of tax credits, incentive payments, or
grants to facilitate compliance.246 As noted above, such inducements
have already been suggested in several Congressional bills.247
According to many experts, governmental investments in HIT
will be well worth their cost.248 While the expenses of purchasing and
implementing EHR systems will likely reduce net savings initially,
savings are predicted to rise sharply once the systems have been fully
implemented.249 Assuming a base year of 2004, one study anticipated

244. See supra notes 156–59 and accompanying text (discussing incentives for EHR system adoption).
245. See supra notes 131–38 and accompanying text (discussing the costs and burdens of
EHR system implementation).
246. See CONG. BUDGET OFFICE, supra note 80, at 27 (discussing the funding activities
of the federal government and options for further promotion of HIT).
247. See supra notes 160–62 and accompanying text (discussing relevant legislative proposals).
248. See, e.g., Hillestad et al., supra note 61, at 1115 (2005) (“[T]here is substantial rationale for government policy to facilitate widespread diffusion of interoperable HIT.”).
249. See id. at 1114–15; Walker et al., supra note 80, at W5-16.
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net national savings of $21.3 billion at year five, $59.2 billion at year
ten, and $77.4 billion at year fifteen.250
A program of incentive payments or grants could be administered
by the Agency for Healthcare Research and Quality (“AHRQ”),
which is HHS’s health research services arm.251 One of the agency’s
functions is to serve as “a major source of funding and technical assistance for health services research and research training at leading U.S.
universities and other institutions.”252 AHRQ, therefore, has considerable experience in administering grant programs253 and has already
provided funding for numerous HIT-related projects.254
2. WorldVistA
One approach that could alleviate funding pressures and facilitate
development of an NHIN is widespread adoption of the VA’s VistA
system.255 VistA is an open source product.256 However, it is written
in a programming language, MUMPS, that is currently unfamiliar to
most programmers,257 and it is not interoperable with other systems.258
Furthermore, the VA does not offer assistance with installation and
maintenance to those who adopt VistA, and therefore users must hire
vendors for these purposes.259
250. FEDERICO GIROSI ET AL., RAND HEALTH, EXTRAPOLATING EVIDENCE OF HEALTH
INFORMATION TECHNOLOGY SAVINGS AND COSTS 35–36 (2005), available at
http://www.rand.org/pubs/monographs/2005/RAND_MG410.pdf.
251. See What Is AHRQ?, http://www.ahrq.gov/about/whatis.htm (last visited Dec. 19,
2008).
252. Id.
253. See Health Care: Funding Announcements, http://www.ahrq.gov/fund/grantix.htm
(last visited Dec. 19, 2008) (listing grant programs administered by AHRQ).
254. AHRQ National Resource Center for Health IT, http://healthit.ahrq.gov/portal/
server.pt (last visited Dec. 19, 2008) (discussing AHRQ-funded state and regional HIT
initiatives, e-prescribing pilot projects, and other undertakings).
255. See Goetz, supra note 131.
256. VistA Software Alliance, Vendors & Resources, http://www.vistasoftware.org/
resources/index.html (last visited Dec. 19, 2008).
257. See Posting of Ignacio Valdes to LinuxMedNews, VistA and MUMPS: Big, Ugly
and Proud, http://www.linuxmednews.com/1130420416/index_html (Oct. 27, 2005 8:40
EDT) (“MUMPS is also loathed by programmers . . . .”).
258. Kupersmith et al., supra note 40, at w157–58 (describing the VA’s EHR system);
The Last Frontier: Bringing the IT Revolution in Healthcare: Hearing Before the H. Comm.
on Government Reform, 109th Cong. (2005), (statement of Robert M. Kolodner, M.D.,
Chief Health Informatics Officer Veterans Health Administration Department of Veterans
Affairs), available at http://www.va.gov/OCA/testimony/hgrc/050929RK.asp (stating that
“[w]ithout data standards, we might be able to exchange health information, as we do now
when we copy and send paper records, but we won’t be able to use it as effectively to deliver safer, higher-quality care” and that “[t]rue interoperability between providers simply
cannot be achieved without data standardization”).
259. See VistA Software Alliance, Vendors & Resources, supra note 256 (listing VistA
service providers); see also Goetz, supra note 131 (stating that the VA is prohibited by law
from straying from its mission to serve veterans and, consequently, it will not assist entities
in installing or maintaining the system).
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In 2002, a group of VA programmers formed WorldVistA, which
aims to extend and modify VistA for use outside the VA system and
to assist users in mastering, installing, and maintaining the software.260 The group received a grant from CMS to support its work.261
In May 2007, a WorldVistA product for ambulatory care settings,
WorldVistA EHR VOE/ 1.0, attained certification from CCHIT262 and
thus could be broadly adopted by physicians.263
Critics note that WorldVistA’s staffing and billing functions are
weak.264 In addition, WorldVistA cannot be customized as easily as
some other commercially available systems, and some feel its graphical interface is not particularly user-friendly or appealing.265 While
these shortcomings are significant, the cost of obtaining a license and
support contract for WorldVistA is about ten percent of the cost of
obtaining these items for other systems, according to one source.266
However, the costs of installation, training, maintenance, and related
activities may not be significantly lower.
The jury is still out as to whether the WorldVistA system can be
sufficiently improved to become a broadly adopted, effective, and low
cost alternative for health care providers. This option, however, is
certainly worth exploring.
B. Regulating Approval and Oversight of EHR Systems
CCHIT has promoted EHR system quality by developing certification criteria and certifying ambulatory care and hospital EHR products through its testing program.267 Without CCHIT, EHR systems
would not be subject to oversight of any kind.268 However, assigning
certification of EHR systems exclusively to CCHIT, an industry-based
association, is inadequate. Instead, we recommend that federal regulations establish a multi-step process that will involve scrutiny by a variety of parties. Regulatory requirements should apply to all parties
who develop or modify EHR system software, install it, or integrate it
with existing systems. Health care providers who perform these func-

260. See Goetz, supra note 131; Welcome to the WorldVistA Homepage,
http://worldvista.org (last visited Dec. 19, 2008); About WorldVistA, http://worldvista.org/
WorldVistA (last visited Dec. 19, 2008).
261. Goetz, supra note 131.
262. See supra Part III.A.3 for detailed discussion of CCHIT.
263. WorldVistA EHR — CCHIT Certification Commission for Healthcare Information
Technology, http://www.cchit.org/choose/ambulatory/2006/WorldVistA-EHR.asp (last
visited Dec. 19, 2008).
264. See, e.g., Goetz, supra note 131.
265. Id.
266. Id.
267. See CCHIT: Certification Commission for Healthcare Information Technology,
http://www.cchit.org/certify/index.asp (providing information about CCHIT certification).
268. See supra notes 201–04 (explaining that the FDA does not regulate EHR systems).
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tions themselves should be deemed vendors for legal purposes relating
to EHR system activities ordinarily performed by vendors.
The essential components of our recommendations are the following: (1) field testing of all new products for a significant period of
time; (2) use of local EHR System Oversight Committees that will in
some ways resemble Institutional Review Boards (“IRBs”);269 (3) premarketing product approval by the regulatory agency; and (4) ongoing, post-marketing monitoring by the Committees and the regulating
agency to ensure that adverse event data is collected, that vendors
respond to users’ requests for assistance, and that system failures are
promptly investigated and addressed so that adverse health outcomes
are avoided or minimized. These elements are developed below.
1. Initial Approval of New Products
New EHR systems should not be available for use without approval by the regulatory agency. To begin the approval process, applicants seeking EHR system approval would submit to the regulating
agency270 the following items: project plans; software requirements
and specifications; software designs; test plans; test reports; documentation for users and system administrators; and related documents.
The material should include guidelines concerning how and to what
extent health care providers can safely customize the product, together
with a technical justification for why the permissible customizations
are considered safe.
Actual testing of the system would commence with “in house”
testing by the system developer. In addition, developers may choose
to retain CCHIT to conduct the one-day testing program that it currently offers,271 though they would not be required to do so. CCHIT
review might be useful because it could alert developers to problems
that they had not detected through internal testing prior to launching
their products for pilot testing in the field.
Prior to approval, EHR systems would be field tested for a period
of at least six months under varied and representative usage conditions.272 Such testing is needed because the occurrence of software
failures may be highly dependent on the local operating environment
and patterns of usage.273 The FDA recognizes the need to test soft269. See 21 C.F.R. § 56.102(g) (2007) (defining “Institutional Review Board”).
270. See supra Part III.B for discussion of which agency should have regulatory authority.
271. See supra notes 190–95 and accompanying text (discussing the CCHIT testing program).
272. See Richards, supra note 20, at 27 (discussing the importance of creating “a realworld test environment”).
273. John Musa et al., The Operational Profile, in HANDBOOK OF SOFTWARE
RELIABILITY AND SYSTEM RELIABILITY 167, 167 (Michael R. Lyu ed., 1996) (“A softwarebased product’s reliability depends on just how a customer will use it.”).
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ware in medical devices at the user site.274 CCHIT has also recognized
the need for systems to be observed in the field. It requires that they
be in operation at one or more locations for forty-five days prior to
testing.275 This requirement, however, is not sufficiently rigorous,
because such a limited evaluation does not account for variations in
function usage across sites or over time. Indeed, within the first fortyfive days, users may not even become thoroughly familiar with a system or use all of its functions.276 We recommend that systems designed for hospitals be tested at a small number of medium to large
hospitals and that systems designed for ambulatory care settings be
tested in a larger number of provider offices.
The regulating agency should publish site-selection and testingperiod guidelines and evaluation metrics for different types of EHR
systems. The guidelines should be based upon sound survey methodology277 so as to ensure that meaningful statistical estimates of adverse incident frequency, software reliability,278 and other relevant
measures are obtained.
2. The Role of Local System Oversight Committees
Effective approval and monitoring of all EHR systems in the U.S.
could not be accomplished solely by the regulatory agency. Rather, it
will have to be led by local entities that are sufficiently resourced to
achieve thorough and constant oversight. We will call these entities
EHR System Oversight Committees (“SOCs”), and we contemplate
that they will be similar in some ways to IRBs.279 The use of SOCs for
oversight of clinical software systems of various kinds was proposed a
decade ago in an article written by two medical informatics experts,

274. FDA, GENERAL PRINCIPLES OF SOFTWARE VALIDATION; FINAL GUIDANCE FOR
INDUSTRY AND FDA STAFF 27 (2002), available at http://www.fda.gov/cdrh/comp/
guidance/938.pdf.
275. CERTIFICATION HANDBOOK, supra note 184, at 45 (requiring that products be in
production use for forty-five calendar days in at least one location).
276. See Linda M. Culp et al., Phased Implementation, in IMPLEMENTING AN EHR
SYSTEM, supra note 20, at 111, 111 (discussing the importance of spreading “the users’
learning over time” and “producing several manageable peaks in cognitive load”).
277. See generally RISTO LEHTONEN & ERKKI PAHKINEN, PRACTICAL METHODS FOR
DESIGN AND ANALYSIS OF COMPLEX SURVEYS (2004).
278. See SOMMERVILLE, supra note 197, at 208–09, 801 (explaining that reliability metrics are used to specify software reliability, that is, the system’s ability to “deliver services
as specified”).
279. See Sharona Hoffman, Regulating Clinical Research: Informed Consent, Privacy,
and IRBs, 31 CAP. U. L. REV. 71, 76–78 (2003) (discussing IRBs and their functioning).
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Randolph Miller and Reed Gardner,280 and several of our recommendations overlap with theirs.281
Hospitals and physician networks with sufficient IT resources
would have their own SOCs. Local SOCs would also be created to
serve resource-poor hospitals or individual providers’ offices that
wish to join together for SOC purposes.282 Just as federal regulations
govern the composition of IRBs,283 regulations would specify guidelines for the number, expertise, and diversity of SOC members.
Vendors would need to convince provider facilities to agree to
field test new EHR systems. Participating providers would have to
enter existing patient records into the EHR system that is to be tested,
which can be an onerous task; therefore, vendors would likely find it
necessary to offer significant incentives.284 Providers might be willing
to serve as field testers only if they are convinced that the product is
superior to others that have already been approved or is equivalent to
others but is less expensive. To this end, a positive evaluation from
CCHIT based on its one-day testing process285 might be influential.
Furthermore, vendors could offer field testers product discounts, free
support services, and other payments or benefits, and they could
promise that, in the event their product is not ultimately approved by
the regulating agency, they will provide reimbursement for expenses
incurred in testing the system.
SOCs would charge vendors a review fee, but this would not constitute a novel or unacceptable requirement. CCHIT charges a fee,286
as do IRBs that operate for profit and bill for protocol reviews.287
Drug and device manufacturers seeking FDA approval have also become accustomed to paying the FDA user fees pursuant to the Pre-

280. See Miller & Gardner, supra note 203, at 450 (recommending review of clinical
software systems by Software Oversight Committees, composed of individuals with expertise in “health care informatics, clinical practice, data quality, biomedical ethics, patients’
perspectives, and quality improvement”).
281. See the footnotes in this Part for references to relevant proposals in the Miller &
Gardner article.
282. See Miller & Gardner, supra note 203, at 450 (suggesting that small practitioners’
offices and hospitals could “participate in regional SOCs, or possibly request consultations
from local SOCs at larger institutions”).
283. 21 C.F.R. § 56.107 (2007) (discussing IRB membership).
284. In some cases, facilities may be allowed to test EHR systems using a subset of their
patient records rather than all of them. The regulatory agency will need to develop guidelines as to how many records must be included in order to obtain statistically significant
field testing results.
285. See supra notes 190–93 and accompanying text (discussing the CCHIT testing program).
286. See CERTIFICATION HANDBOOK, supra note 184, at 66 (detailing fees for CCHIT
testing).
287. See Sharona Hoffman & Jessica Wilen Berg, The Suitability of IRB Liability, 67 U.
PITT. L. REV. 365, 404 (2005) (discussing for-profit IRBs).

No. 1]

Electronic Health Record Systems

45

scription Drug User Fee Act288 and the Medical Device User Fee and
Modernization Act of 2002.289 Furthermore, the FDA at times relies
on paid third party reviewers during the device approval process. In
some circumstances, device manufacturers may request that their facility inspection be conducted by an “accredited person” rather than
by an FDA official.290
Despite being paid a fee by vendors, SOCs are more likely to be
neutral than CCHIT, because most of their members would not be
HIT industry personnel. Rather, their membership would include hospital HIT staff, physicians and other health care workers, community
members representing patients, academics, and others. These individuals are likely to prioritize the best interests of practitioners and
patients over the interests of industry and thus to subject EHR systems
to rigorous evaluation.
The SOCs would oversee testing, review field testing results, and
produce a report evaluating the EHR system upon completion of testing. The EHR system vendor would then submit required documentation, including the SOC’s report, to the regulatory agency, which
would have ultimate approval authority.291
While this multi-step process may seem onerous, it is no more
burdensome than the traditional FDA approval process for new drugs.
The FDA approval process entails animal testing, human testing in
three separate phases of clinical trials, review of safety and efficacy
research by an FDA review team, FDA review of labeling information, and an FDA facility inspection.292 EHR systems, which are vital
to patient health and welfare, must similarly be subjected to rigorous
review.293
EHR systems that are already CCHIT-certified294 and are in use at
the time the regulations go into effect would not need to be approved
288. 21 U.S.C.A. § 379h (West 1999 & Supp. 2008) (detailing fees that those submitting
human drug applications must pay).
289. Id. § 379j(a) (detailing fees that those submitting PMAs must pay).
290. See id. § 360m (authorizing review by accredited persons); see also Accredited Persons Inspection Program, http://www.fda.gov/cdrh/ap-inspection/ap-inspection.html (last
visited Dec. 19, 2008) (describing the program and its operation). An “accredited person” is
one who is certified through an accreditation program to conduct certain review functions.
The qualifications for accredited persons are listed in 21 U.S.C.A. § 360m(b)(3).
291. See 21 C.F.R. §§ 814.20, 814.40 (2007) (discussing items that must be included in
submissions for pre-market approval and the FDA’s authority to approve and disapprove
these submissions).
292. Michelle Meadows, The FDA’s Drug Review Process: Ensuring Drugs Are Safe and
Effective, FDA CONSUMER MAGAZINE, July/Aug. 2002, at 19, 21, available at
http://www.fda.gov/fdac/special/testtubetopatient/drugreview.html.
293. As technology develops, some safety-critical components of EHR system decision
support, such as diagnostic algorithms designed to detect various cancers, may need to be
separately evaluated. In such cases, traditional clinical trials may be appropriate, and these
could be referred to the FDA or overseen by the agency that regulates EHR systems.
294. See CERTIFICATION HANDBOOK, supra note 184, at 8 (noting that over 100 products
have been certified by CCHIT).
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by the regulating agency. It would be unrealistic and excessively disruptive to require providers to suspend use of EHR systems upon
which they already depend in order to subject them to lengthy approval processes. If such demands were made, physicians would have
to return temporarily to using paper records and might lose access to
critical medical history and other information about their patients.
Systems that are already in use would be subjected to the reporting
and monitoring requirements outlined below,295 which should be sufficient to detect any product flaws that require corrective intervention.
3. The Need for Continued Monitoring
The operating conditions that an EHR system encounters when it
is broadly deployed may differ from those it encountered during field
testing. Furthermore, the system itself may be changed by the vendor
or by users, for example, to fix defects, add new features, or accommodate local preferences. Therefore, system monitoring should continue for the operational lifetime of the product.
To facilitate timely recognition of and response to emerging problems, EHR system vendors would be required to provide several mechanisms by which users can report difficulties. These would include
a feature that is incorporated into the EHR system itself, such as a
button labeled “Report System Problem,” a vendor website through
which problem reports can be submitted, and a dedicated e-mail address and phone number for reporting problems.296
EHR vendors would notify the SOCs overseeing affected facilities of all problems and categorize problems in terms of severity and
potential impact on patients and providers.297 Early in the process of
EHR system implementation, it is likely that a large percentage of
problems will be minor ones, resulting from users’ lack of familiarity
with the system. Once problems are resolved, vendors would notify
SOCs and explain the resolutions. As a safeguard against vendors
concealing problems, users could also be encouraged to report significant problems directly to their SOCs through SOC websites or email.298
All SOCs, in turn, would provide the regulatory agency with
semi-annual reports of significant EHR system problems, their resolu295. See infra Part IV.B.3 and accompanying text (discussing continued monitoring of
EHR systems).
296. Cf. Elizabeth A. Boyer & Michael W. Soback, Production Support, in
IMPLEMENTING AN EHR SYSTEM, supra note 20, at 95, 95 (discussing how an EHR help
desk should operate).
297. See id. at 96 (describing a methodology for classifying and tracking problems).
298. See Miller & Gardner, supra note 203, at 450–51 (stating that SOCs should monitor
user complaints and ensure that vendors provide users with a help desk and correct software
problems); see also CERTIFICATION HANDBOOK, supra note 184, at 43 (discussing CCHIT’s
“Purchaser Complaint Process”).
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tions, and accounts of vendors’ failures to address serious problems.299 However, SOCs and vendors would immediately report to the
regulating agency any serious problems that might endanger the
health of patients so that the agency can oversee the remediation process and, if necessary, investigate and impose appropriate penalties.
The FDA has established similar adverse event reporting requirements
for user facilities, importers, and manufacturers of devices.300
The regulatory agency should post confirmed problem reports on
its website so that consumers who are considering purchasing new
EHR systems can evaluate them in light of all available information.301 The reports should, however, delete trade secret information,
confidential commercial and financial information, patient information, and information about the identities of the users who reported the
adverse events.302 This practice would follow the precedent established by the FDA, which has the authority to disclose redacted adverse event reports for medical devices.303
Software vendors routinely modify their systems to repair defects
and add new features.304 Any change to existing software, including
EHR system software, creates the possibility of operational failures
due to newly introduced defects.305 The FDA has indicated that 7.7%
of medical device recalls between 1992 and 1998 were attributable to
software failures, and among these, 79% of recalls were due to defects
introduced by changes made after the software was initially produced
and distributed.306
Vendors would report proposed system modifications to the
SOCs that field tested their products with a good faith assessment of
their potential impact on providers and patients.307 SOCs would have
299. See Miller & Gardner, supra note 203, at 451 (suggesting that SOCs should report
product problems to the FDA).
300. 21 C.F.R. § 803.1 (2007).
301. See Miller & Gardner, supra note 203, at 451 (recommending that the FDA “collect
and distribute aggregated, standardized reports of system-specific and global problems”).
302. Cf. 21 C.F.R. § 803.9 (2007) (discussing public disclosure of medical device reports).
303. 21 C.F.R. §§ 803.9, 814.44(d) (2007); see Aaron Kesselheim & Michelle Mello,
Confidentiality Laws and Secrecy in Medical Research: Improving Public Access to Data
on Drug Safety, 26 HEALTH AFF. 483, 489–90 (2007) (calling for regulatory and legislative
changes that would require the FDA to expand its disclosure of safety data so that researchers can independently assess drug safety and efficacy).
304. See SOMMERVILLE, supra note 197, at 488–511 (discussing software evolution).
305. See Elizabeth Boyer et al., System Integration, in IMPLEMENTING AN EHR SYSTEM,
supra note 20, at 89, 94 (“[M]ajor upgrades can create enough data integrity and usability
problems to pose a serious threat to patient safety and workflow efficiency.”); Nayar &
Miller, supra note 112, at 48 (discussing various changes that can threaten the integrity of
EHRs).
306. FDA, supra note 274, at 3.
307. See CERTIFICATION HANDBOOK, supra note 184, at 47–49 (discussing how CCHIT
addresses minor and significant product changes). EHR systems should be designed so that
changes to the system configuration can be made only by authorized system administrators
and not by ordinary users. This constraint should apply even to seemingly minor user-
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authority to approve minor changes but would report major changes to
the regulatory agency, which in turn could require a new approval
process, including field testing.308
Vendors are not the only parties that might alter EHR systems.
Health care providers themselves often customize the systems they
use, for example, to accommodate their preferred workflows.309 While
many customizations entail little risk, others, such as customizing decision support rules, can impact patient welfare.310 Health care providers who wish to make configuration changes or customizations to
EHR systems that do not conform to approved customization guidelines311 or that directly impact patient safety would report their proposed alterations to their SOCs. The SOCs would scrutinize the
proposals to determine their potential impact on patient care and approve or disapprove them. While both SOCs and the regulatory agency would oversee significant system changes made by vendors,312 the
SOCs alone can oversee configuration changes and customizations
made by health care providers.
The need to monitor technologically sophisticated devices has
been acknowledged by industry and government. CCHIT has recognized the need for periodic recertification of products.313 Likewise,
Congress has authorized the Secretary of HHS to order postmarketing studies of devices whose malfunctions could lead to “serious adverse health consequences.”314 EHR systems are life-critical
devices that demand similar attention.
Finally, the regulatory agency could maintain a feature on its
website by which users can post comments concerning EHR systems
that regulators will consider for purposes of future policy setting.

interface changes, such as moving windows, because such changes could obscure clinically
relevant information.
308. See id. Changes designed to fix system bugs, however, should be deployed before
they are approved by an SOC or the regulatory agency.
309. See Jean A. Adams et al., Workflow Assessment and Redesign, in IMPLEMENTING AN
EHR SYSTEM, supra note 20, at 36, 36–39 (discussing tailoring workflows for particular
organizations).
310. For example, alerts and reminders that appear at the wrong time during the treatment
encounter might fail to influence care decisions and improve health outcomes. See James M.
Walker & Stephen T. Tingley, Clinical Decision Support, in IMPLEMENTING AN EHR
SYSTEM, supra note 20, at 67, 70 (“If the reminder can only be presented after the physician
has decided on a course of action and recommended it to the patient, it is likely to be ignored.”).
311. See supra note 270 and accompanying text (discussing customization features and
their approval).
312. See Boyer et al., supra note 305, at 93–94 (advocating a “structured approach” to
large system upgrades).
313. CERTIFICATION HANDBOOK, supra note 184, at 3.
314. 21 U.S.C.A. § 360l (West 1999 & 2008).
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HHS and CMS already maintain interactive sites that allow the public
to submit questions and feedback.315
While the proposed regulatory scheme may appear to entail the
creation of a large and costly government bureaucracy, this need not
be the case. CCHIT certified fewer than sixty-five products under its
2007 criteria.316 Thus, the number of EHR systems for which approval
is sought at any given time is likely to be limited. In addition, if more
stringent approval and monitoring requirements are implemented,
vendors may be even more cautious and selective in attempting to
introduce new products to the market.
C. EHR System Standards and Criteria
Regulators with specialized expertise will need to formulate the
regulations carefully, in light of input received from various stakeholders through the statutorily mandated notice and comment period.317 The agency will also likely find it necessary to periodically
augment and revise the regulations and issue interpretive guidance to
respond to the rapid pace of technological change. In this Section, we
highlight only a few standards and requirements that deserve special
emphasis and explanation.
1. Best Practices Standard
The task of crafting clear guidance concerning health information
technology, software engineering methodology, and computer security practices is particularly challenging. These domains are continually changing, and thus it is very difficult to create static rules to
govern them.318
Consequently, we recommend the adoption of a “best practices”
standard. Specifically, the regulations should require EHR system
vendors and health care providers to make reasonable efforts to identify and employ best practices relating to all of the following: hazard
and risk analysis and mitigation; software development, validation,
315. Submit
Feedback:
Centers
for
Medicare
&
Medicaid
Services,
http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg/php/enduser/ask.php (last visited Dec. 19,
2008); United States Department of Health & Human Services, Office for Civil Rights,
http://www.hhs.gov/ocr/contact.html (last visited Dec. 19, 2008).
316. See CCHIT Certified Ambulatory EHR 2007, http://www.cchit.org/choose/
ambulatory/2007/index.asp (last visited Dec. 19, 2008); CCHIT Certified Inpatient EHR
2007, http://www.cchit.org/choose/inpatient/ 2007/index.asp (last visited Dec. 19, 2008).
317. See 5 U.S.C. § 553(b)−(c) (2006) (establishing notice and comment requirements for
proposed administrative rules). Initially, regulators may need to solicit input from industry
members who are unfamiliar with the regulatory process. To this end, regulators may want
to take advantage of eRulemaking initiatives, which allow the public to access and comment
upon proposed federal regulations through the Internet. See Regulations.gov,
http://www.regulations.gov/search/about.jsp (last visited Dec. 19, 2008).
318. See Hoffman & Podgurski, supra note 115, at 11.
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and maintenance; security measures; and system integration and operation. The practices identified should be either commonly used by
organizations doing similar work or clearly superior to best common
practices. The best practices standard is intended to motivate EHR
system vendors to continually maximize the dependability of their
products.
Vendors and health care providers could refer to consensus guidelines formulated by well respected professional organizations, such as
the International Organization for Standardization (“ISO”),319 or they
could refer to HIT and software engineering publications. Regulators
may choose to incorporate certain consensus guidelines by explicit
reference in the regulations. In addition, on its website, the regulating
agency could maintain a list of resources from which vendors and
health care providers could draw guidance concerning best practices.
2. Interoperability
The federal regulations must address interoperability because it is
essential to fully realizing the potential benefits of EHR systems for
both clinical operations and medical research.320
Efforts to achieve HIT interoperability have been underway for
many years. For example, in 1987, an ad hoc standards group called
Health Level 7 (“HL7”) was established to provide a standard for the
exchange of information among hospital computer systems.321 Now
HL7 has in excess of 500 organizational members and 2200 individual members, and its data messaging standard is in use at over 1500
medical facilities.322 Yet, despite HL7 and a number of other longterm efforts to achieve full interoperability of health information systems,323 progress has been slow.324
319. ISO — International Organization for Standardization, http://www.iso.org/iso/
home.htm (last visited Dec. 19, 2008).
320. See supra Part II.B.1 (discussing the importance of interoperability); see also Marco
Eichelberg et al., A Survey and Analysis of Electronic Healthcare Record Standards,
37 ACM COMPUTING SURVS. 277, 278 (2005) (“Making EHRs interoperable will contribute
to more effective and efficient patient care by facilitating the retrieval and processing of
clinical information about a patient from different sites [among other benefits].”); Sebastian
Garde et al., Towards Semantic Interoperability for Electronic Health Records: Domain
Knowledge Governance for openEHR Archetypes, 46 METHODS INFO. MED. 332, 340–41
(2007) (discussing the importance of interoperability).
321. BIOMEDICAL INFORMATICS, supra note 1, at 300.
322. Id. at 301.
323. See Eichelberg et al., supra note 320, at 278 (discussing various standards that are
being developed to address EHR interoperability problems).
324. B.G.M.E. Blobel et al., Semantic Interoperability: HL7 Version 3 Compared to Advanced Architecture Standards, 45 METHODS INFO. MED. 343, 345 (2006) (acknowledging
the lengthy evolution of HL7, characterized by a “frequent change of direction” and an
“endless series of versions,” but expressing optimism that HL7 is a maturing standard that is
steadily improving); see Barry Smith & Werner Ceusters, HL7 RIM: An Incoherent Standard, 124 STUD. HEALTH TECH. & INFORMATICS 133, 133–38 (2006) (“[A]fter ten years of
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The most relevant form of interoperability for our purposes is semantic interoperability, by which we mean “the ability of information
systems to exchange information on the basis of shared, preestablished and negotiated meanings of terms and expressions.”325 In
the context of EHR systems, this definition implies that all or part of
an EHR created or updated on one system can be transmitted to other
vendors’ systems in a way that permits the receiving systems to interpret and utilize the transmitted data as efficiently and effectively as
they use their own internally created EHRs.326
One obstacle to achieving semantic interoperability between EHR
systems is the fact that medical terminology is complex, variable, and
evolving. Terminology varies between medical specialties, locales,
and health care facilities, and it also varies with clinical context.327
For example, the abbreviation “MS” stands for “mitral stenosis” in
cardiology, “multiple sclerosis” in neurology, “morphine sulfate” in
anesthesia, and “magnesium sulfate” in obstetrics.328 EHR systems
that use different medical terminologies cannot communicate effectively with each other without an accurate translation between their
terminologies.
Another barrier to achieving semantic interoperability is the fact
that existing EHR systems produced by different vendors employ proprietary internal representations of medical information that are generally incompatible with one another.329 To address this problem, it is
necessary for all vendors to support what we will call a “common exchange representation” (“CER”) for EHRs. A CER is an artificial language for representing the information in EHRs, which has well
defined syntax and semantics and is capable of unambiguously repreeffort, and considerable investment . . . , the promised benefits of interoperability remain
elusive[.]”).
325. Kim H. Veltman, Syntactic and Semantic Interoperability: New Approaches to
Knowledge and the Semantic Web, 7 NEW REV. INFO. NETWORKING 159, 167 (2001).
326. This is the type of interoperability sought by HL7, one of whose core strategies is to
“[d]evelop coherent, extendible standards that permit structured, encoded health care information of the type required to support patient care, to be exchanged between computer
applications while preserving meaning.” About HL7, http://www.hl7.org/about/
hl7about.htm (last visited Dec. 19, 2008). Simply converting an EHR to human-readable
text and transmitting it to another system does not constitute semantic interoperability if the
receiving system cannot automatically distinguish the elements of the EHR, such as symptoms, test results, diagnoses, and drug orders, and process them appropriately.
327. Some commentators argue that the development and maintenance of a semantically
interoperable representation for health information needs to be coordinated internationally
and across health disciplines, a process that has been called “domain knowledge governance.” See Garde et al., supra note 320, at 336–38.
328. Christopher G. Chute, Medical Concept Representation, in MEDICAL INFORMATICS:
KNOWLEDGE MANAGEMENT AND DATA MINING IN BIOMEDICINE 170 tbl.6-1 (Hsinchun
Chen et al. eds., 2005).
329. See, e.g., Rong Chen et al., Julius — A Template Based Supplementary Electronic
Health Record System, BMC MED. INFORMATICS & DECISION MAKING, May 2, 2007,
http://www.biomedcentral.com/1472-6947/7/10 (discussing attempts to combine EHR systems in three facilities in Stockholm, Sweden that encountered this problem).

52

Harvard Journal of Law & Technology

[Vol. 22

senting the information in any EHR from a typical EHR system.
EHRs using the CER should be readily transmittable between EHR
systems of different vendors. The CER should make it easy for vendors of EHR systems to implement a mechanism for translating accurately and efficiently between the CER and the system’s internal EHR
format.330 A CER should be based on a standardized clinical terminology such as SNOMED-CT.331
Financial disincentives constitute a further impediment to interoperability. Interoperability may be disfavored by providers because it
makes it easier for patients to change doctors by allowing complete
patient files to be shared or transferred electronically to other facilities.332 Additionally, clinicians may be resistant to facilitating the
sharing of patient data because they are sensitive to confidentiality
issues and will worry that electronically transmitted EHRs will be
accessed by unauthorized personnel or inadvertently distributed to
persons with whom they should not be shared.333 At the same time,
some providers may be concerned that other clinicians who scrutinize
their EHRs may accuse them of malpractice.
EHR system vendors may also find interoperability unappealing
because it makes it easier for providers who have one EHR system to
switch to another by enabling patient EHRs to be easily transferred
between systems. Without interoperability, the difficulty of transferring hundreds or thousand of EHRs between different systems may
deter providers from changing their EHR vendors.
Although HIT has been developing over several decades, interoperability is an elusive goal, and the industry has seen a proliferation of
non-interoperable products.334 Today, we are far from achieving a

330. See Marco Eichelberg et al., Electronic Health Record Standards — A Brief Overview, 2006 ITI 4TH INT’L CONF. ON INFO. & COMM. TECH., available at
http://www.srdc.metu.edu.tr/webpage/projects/ride/publications/icict06_20060810.pdf
(discussing EHR standards that would enable information exchange). An example of a
proposed exchange representation for medical information is the HL7 Clinical Document
Architecture (“CDA”). See Robert H. Dolin et al., The HL7 Clinical Document Architecture,
8 J. AM. MED. INFORMATICS ASS’N 552, 552–69 (2001).
331. See IHTSDO: International Health Terminology Standards Development Organisation, http://www.ihtsdo.org/ (last visited Dec. 19, 2008); see also PRESIDENT’S INFO. TECH.
ADVISORY COMM., REVOLUTIONIZING HEALTH CARE THROUGH INFORMATION
TECHNOLOGY 21–22 (2004), available at http://www.itrd.gov/pitac/reports/20040721_hit_
report.pdf (recommending that SNOMED-CT be incorporated into EHR systems).
332. David J. Brailer, Interoperability: The Key to the Future Health Care System,
25 HEALTH AFF. W5-19, W5-20 (2005), (noting that without interoperability a health care
enterprise “hopes to gain comparative advantage by imposing high costs on consumer
switchover and by exercising market leverage over small-niche players such as solo physicians and community hospitals”).
333. See 45 C.F.R. §§ 160.101–.534 (2007) (emphasizing the importance of the privacy
and security of health information).
334. See supra text accompanying notes 178–81 (discussing obstacles to interoperability).
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fully interoperable NHIN.335 According to some commentators, “the
strategy of building the network from the bottom up by establishing
many RHIOs throughout the country is not working.”336 Because of
funding shortages, only a handful of RHIOs are fully operational and
self-sustaining.337 The only mechanism that is likely to achieve true
nationwide interoperability, other than a monopoly of the EHR market, is a federal mandate that any EHR system that is approved for
clinical use must support a specified CER.338
3. Audit Trails and Capture/Replay
Because EHR systems are extremely complex, regulators and litigants might find it impossible to discern certain system malfunctions
without audit trails or capture/replay, even if they employ knowledgeable experts. A computer system audit trail is a “generalized recording
of ‘who did what to whom, when, and in what sequence.’”339 It is also
possible to design software to capture its interaction with users or with
another system in such a way that the interaction can be replayed exactly as it happened, including graphical, as opposed to only textual,
output.340 Requiring either mechanism for EHR systems would be
analogous to the HIPAA Security Rule’s requirement of audit controls
for systems that process electronic health information341 and to the
Federal Aviation Administration’s mandate that certain airplanes be
equipped with flight data recorders.342
Audit trails and capture/replay would enable experts to determine
whether and why EHR system malfunctions occurred and to implement appropriate interventions. Such mechanisms could also assist
both defendants and plaintiffs in litigation by facilitating the reconstruction of facts. Furthermore, they could ease the burdens of discovery by allowing for electronic rather than manual searches of records.
335. See Day, supra note 35, at 1011 (explaining that “very few systems today are interoperable” and that EHR exchanges will be limited to local and regional RHIOs rather than
to an NHIN for “some time to come”).
336. CASTRO, supra note 57, at 10.
337. See id.; Julia Adler-Millstein et al., The State of Regional Health Information Organizations: Current Activities and Financing, 27 HEALTH AFF. w60, w63, w65–w66 (reporting on a survey of 138 RHIOs that found that 26% were defunct, “only twenty were
functioning at even a modest scale, and only fifteen were doing so for a broad set of patients”).
338. See PRESIDENT’S INFO. TECH. ADVISORY COMM., supra note 331, at 24–25 (discussing the importance of developing “a single set of data standards for the most common
forms of clinical information”).
339. Lawrence A. Bjork, Jr., Generalized Audit Trail Requirements and Concepts for Data Base Applications, 14 IBM SYS. J. 229, 229 (1975).
340. John Steven et al., jRapture: A Capture/Replay Tool for Observation-Based Testing,
2000 PROC. ACM SIGSOFT INT’L SYMP. ON SOFTWARE TESTING & ANALYSIS 158, 158
(discussing capture/replay capabilities).
341. 45 C.F.R. § 164.312(b) (2007).
342. 14 C.F.R. § 121.343 (2007).
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Because of the safety-critical nature of EHR systems, there
should be a regulatory requirement specifying that the systems include
an audit-trail function that details all interactions between systems and
their users and all interactions among systems. In order to permit effective system validation and problem diagnosis and resolution, such
audit trails ought to include all system input and output that could
affect clinical actions or that could reflect the reliability, safety, usability, and security of the system. It must be noted that the accuracy
of audit logs may be partially compromised by errors in user input,
such as inaccurate recording of body temperature or failure to include
physicians’ observations concerning patient symptoms. However, in
the future, many clinical measurements such as temperature and blood
pressure readings could be transmitted directly from instruments to
EHRs.
We further recommend that all EHR system vendors be required
to support capture/replay capability within a reasonable time after the
enactment of the regulations, unless vendors provide compelling technical evidence that doing so would harm the utility or safety of their
systems. A reasonable implementation period might be five years,
which would give vendors ample time to retrofit capture/replay capability to existing systems, a task that is likely to be more difficult than
incorporating this capability into a new design.343 Vendors, however,
should be required to support at least textual audit trails within a much
shorter period of time, perhaps one year.
4. Addressing Privacy and Security Concerns
The extraordinarily sensitive nature of personal health information makes it essential for EHR systems to be designed and operated
in a way that protects the privacy of patients. In previous work, we
have critiqued the HIPAA Security Rule, which governs the security
of electronic health information, and have made detailed recommendations for enhancing and clarifying its requirements.344 However,
even if these recommendations were adopted in EHR regulations, additional steps would be necessary to address fully the special privacy
and security issues raised by interoperability. Interoperability between
EHR systems requires a CER.345 It also requires a common, standard343. Retrofitting capture/replay capability into an existing system may be difficult for a
vendor if the system’s external interfaces are excessively complex, if they are no longer well
understood due to turnover among the vendor’s programming staff, or if the changes negatively affect the efficiency of the system. Also, there is a risk that new defects could be
inadvertently introduced into the system, so substantial additional testing is necessary.
344. Hoffman & Podgurski, supra note 121, at 359–84 (offering a variety of recommendations for revision of the HIPAA Security Rule to achieve greater data security); Hoffman
& Podgurski, supra note 115, at 11–14 (developing recommendations and illustrating how
they could be implemented); see also supra notes 114–28 and accompanying text.
345. See supra notes 329–30 and accompanying text (discussing the CER).
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ized mechanism by which a provider with a particular EHR system
can expeditiously request and receive patient information that is
stored on a remote EHR system, even if the two systems were developed by different vendors. This capability in turn requires standardized policies and mechanisms for each of the following: identifying
patients and providers; obtaining patients’ consent for EHR access;
granting appropriate access authorization and privileges to providers;
authenticating access requests; and employing cryptographic techniques in order to protect the confidentiality and integrity of EHRs
during transmission.346
As is true for a common exchange format, standardized security
policies and mechanisms are unlikely to be adopted by vendors and
providers without a regulatory mandate. In order to facilitate compliance and provide vendors with clear guidance, the regulatory mandate
might incorporate, by explicit reference, some established and emerging security standards, such as the Internet Engineering Task Force’s
Transport Layer Security (“TLS”) standard347 or its Public-Key Infrastructure (X.509) standard.348
The prospect of an NHIN has sounded alarms among privacy advocates. Some have suggested that individuals should have the choice
of opting out of the NHIN system entirely or of controlling access to
their records. For example, the regulations could require that patients
give specific consent to disclosure of certain types of data, such as
mental health histories.349
In principle, we oppose this approach. A comprehensive NHIN
and full computerization of all health records could not be achieved if
individuals were able to opt out fully or partially. A system that included such a choice could be chaotic, in that records would be divided among paper and electronic files and physicians would be
unable to access needed information quickly. Moreover, the option
346. See PRESIDENT’S INFO. TECH. ADVISORY COMM., supra note 331, at 30–34 (discussing the need for unambiguous patient identification, encryption, and authentication);
Mike Boniface et al., Accessing Patient Records in Virtual Healthcare Organisations,
ECHALLENGES
E-2005,
Oct.
20,
2005,
available
at
http://eprints.ecs.soton.ac.uk/12224/01/eChallenges2005-final.pdf (discussing patient consent, authentication, authorization, and access control); Dimitris Gritzalis & Costas Lambrinoudakis, A Security Architecture for Interconnecting Health Information Systems, 73 INT’L
J. MED. INFORMATICS 305, 308 (2004) (discussing encryption); Hiroshi Takeda et al., An
Assessment of PKI and Networked Electronic Patient Record System: Lessons Learned from
Real Patient Data Exchange at the Platform of OCHIS (Osaka Community Healthcare
Information System), 73 INT’L J. MED. INFORMATICS 311–16 (2004) (describing an example
of encryption in an EHR system).
347. See Transport Layer Security (tls) Charter, http://www.ietf.org/html.charters/tlscharter.html (last visited Dec. 19, 2008).
348. See Public-Key Infrastructure (X.509) (pkix) Charter, http://www.ietf.org/
html.charters/pkix-charter.html (last visited Dec. 19, 2008).
349. Terry & Francis, supra note 11, at 725–30 (proposing various approaches to incorporating patient choice into EHR systems, including data carve-outs and secure envelopes);
see also NCVHS, supra note 114, at 7 (discussing “[m]ethods of individual control”).
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could degrade medical care, because physicians, not realizing that
patients have carved out certain information, might rely on incomplete
medical files. The opt-out alternative could also hinder the transfer of
medical data to additional providers when their expertise is needed on
an emergency basis, and it could prevent hospital emergency rooms
from obtaining information that could save patients’ lives. However,
we leave open the possibility of allowing patients to sequester sensitive information so long as adequate safeguards are implemented.
Such safeguards might include notations in EHRs that information is
missing, emergency access to information if patients are unable to
provide consent, and the availability of complete medication lists for
purposes of ascertaining drug interactions.350
Government mandates concerning patient records that limit patient choice are not unprecedented. In Whalen v. Roe,351 the Supreme
Court evaluated a constitutional challenge to a New York statute that
required that the state be provided with copies of all prescriptions for
certain drugs and that specified detailed security measures for the
storage of that information. The Court upheld the constitutionality of
the statute, finding that it called for a legitimate exercise of the state’s
police power and that its mandates would not constitute an impermissible invasion of privacy or violation of any Fourteenth Amendment
right.352 Following this precedent, one might reason that government
regulations requiring the computerization of all patient records and
their inclusion in an NHIN would also be deemed a lawful and constitutional exercise of federal executive power under the Fifth Amendment.353
5. Decision Support
Federal regulations should require EHR systems to feature state
of the art decision support capabilities.354 These would include
prompts, alerts, treatment suggestions, links to medical literature, and,
as technology develops, increasingly sophisticated diagnostic and analytical tools.355
To the extent possible, decision support would be based on widely accepted clinical practice guidelines (“CPGs”), which are
“[s]ystematically developed statements to assist practitioner and pa350. See Letter from Simon P. Cohn, Chairman, Nat’l Comm. Vital Health Statistics, to
Michael O. Levitt, U.S. Sec’y of Health & Human Servs. (Feb. 20, 2008), available at
http://www.ncvhs.hhs.gov/080220lt.pdf (discussing recommendations for the NHIN and
describing specific elements that could be left to patient control).
351. 429 U.S. 589 (1977).
352. Id. at 602, 606.
353. U.S. CONST. amend. V.
354. See supra Part II.B.2 (discussing decision support).
355. See CPRS USER GUIDE, supra note 39 (detailing features available on the VA’s
CPRS system).
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tient decisions about appropriate health care for specific clinical circumstances.”356 For example, a CPG for the treatment of asthma
could be incorporated into an EHR system as a checklist that appears
when a physician enters information indicating that a particular patient has symptoms consistent with asthma. The feature would alert
physicians as to tests that they should conduct, and it would supply
treatment suggestions. CPGs have been developed by various organizations, including: professional societies, such as the American Medical Association and other physician specialty boards; governmental
entities, such as the AHRQ357 and various state programs; and health
care payers, including health maintenance organizations and health
insurers.358
At this time, over 2000 CPGs have been published.359 The CPGs
vary in quality,360 and some may be designed to suit a specific agenda,
such as cost-cutting.361 EHR system vendors cannot be expected to
incorporate large numbers of competing and possibly irreconcilable
CPGs into their systems, and there is no significant consensus as to
which CPGs are the most useful or reliable. Consequently, we recommend that the AHRQ adopt a certification program for CPGs such
as the process proposed by Professor Arnold Rosoff.362 AHRQ would
not be the first to endorse guidelines. The FDA recognizes a large
number of device-specific consensus standards.363 It allows applicants
seeking device approval to submit abbreviated 510(k) applications364
when the “FDA has recognized a relevant consensus standard.”365
Furthermore, the FDA will approve devices partly based on conformity to recognized standards.366 AHRQ could maintain a website list356. BIOMEDICAL INFORMATICS, supra note 1, at 924.
357. See AHRQ at a Glance, http://www.ahrq.gov/about/ataglance.htm (last visited Dec.
19, 2008).
358. See Michelle M. Mello, Of Swords and Shields: The Role of Clinical Practice
Guidelines in Medical Malpractice Litigation, 149 U. PA. L. REV. 645, 650 (2001).
359. National
Guideline
Clearinghouse,
http://www.guideline.gov/search/
detailedsearch.aspx (last visited Dec. 19, 2008).
360. Carter L. Williams, Note, Evidence-Based Medicine in the Law Beyond Clinical
Practice Guidelines: What Effect Will EBM Have on the Standard of Care?, 61 WASH. &
LEE L. REV. 479, 491–92 (2004) (analyzing the usefulness of CPGs).
361. Mello, supra note 358, at 651.
362. See Arnold J. Rosoff, Evidence-Based Medicine and the Law: The Courts Confront
Clinical Practice Guidelines, 26 J. HEALTH POL., POL’Y & L. 327, 355–65 (2001) (proposing a certification program for CPGs).
363. The FDA maintains a searchable online database of recognized consensus standards,
which currently contains over 700 such standards. Recognized Consensus Standards,
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/Search.CFM (last visited
Dec. 19, 2008).
364. See supra notes 220–24 and accompanying text (discussing 510(k) applications).
365. U.S. FOOD & DRUG ADMIN. CTR. FOR DEVICES & RADIOLOGICAL HEALTH, THE
NEW 510(K) PARADIGM — ALTERNATE APPROACHES TO DEMONSTRATING SUBSTANTIAL
EQUIVALENCE IN PREMARKET NOTIFICATION — FINAL GUIDANCE 9 (1998), at
http://www.fda.gov/cdrh/ode/parad510.pdf.
366. Id.
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ing certified CPGs, much as the FDA maintains a website listing its
recognized consensus standards.367
EHR system vendors would be expected to incorporate appropriate certified CPGs into their systems, and these could be automatically
updated as CPGs change, much as other software updates are automatically downloaded. For example, an EHR system tailored for use
in an endocrinologist’s office would base decision support on the
most up-to-date CPGs for endocrinology, while systems designed for
internists or emergency rooms would need to incorporate a broad
range of CPGs.
The regulations should require EHR system vendors to use available technology to maximize the efficacy and safety of decision support features. Some researchers have found that decision support does
not always change provider behavior.368 Some physicians may distrust
computerized suggestions, may not appreciate a computer telling them
how to practice medicine, or may be too busy to consider computerized recommendations carefully,369 and they may too easily erase
prompts by hitting the escape key.370 The efficacy of decision support
can be enhanced through mechanisms such as automatic prompts that
do not need to be deliberately initiated, highlighting, periodic reminders, and carefully selected default settings.371 As a resource for vendors, the regulating agency could include on its website links to
literature providing suggestions for maximizing the benefit of decision support mechanisms.
6. Enforcement
The regulations would need to include enforcement provisions in
order to ensure compliance. Both EHR system vendors and health
367. See Recognized Consensus Standards, supra note 363.
368. Amit X. Garg et al., Effects of Computerized Clinical Decision Support Systems on
Practitioner Performance and Patient Outcomes, 293 JAMA 1223, 1231–32 (2005) (stating
that the systems’ effects on patient outcomes are not sufficiently studied and are inconsistent
when they are examined); Handler et al., supra note 60, at 1136 (stating that the benefit of
decision support is unclear and often does not seem to affect clinicians’ adherence to recommended guidelines).
369. See Usha Subramanian et al., A Controlled Trial of Including Symptom Data in
Computer-Based Care Suggestions for Managing Patients with Chronic Heart Failure,
6 AM. J. MED. 375, 379–80 (2003) (noting that two thirds of suggestions were disregarded).
370. William M. Tierney et al., Can Computer-Generated Evidence-Based Care Suggestions Enhance Evidence-Based Management of Asthma and Chronic Obstructive Pulmonary
Disease? A Randomized, Controlled Trial, 40 HEALTH SERV. RES. 477, 492 (2005). When
the escape key was disabled, provider adherence to suggestions increased significantly.
Dexter et al., supra note 62, at 968.
371. Dexter et al., supra note 62, at 968 (noting that displaying a banner on the screen
that stated suggestions were available and then requiring physicians to make a deliberate
choice to view reminders was ineffective); Garg et al., supra note 368, at 1234; McDonald
et al., supra note 37, at 244–47 (discussing the Regenstrief system’s automatic suggestions,
which are triggered by various types of data input).
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care providers must be subject to regulatory enforcement. Vendors
would need to ensure that their products conform to regulatory standards and to comply with approval and reporting procedures.372 Providers would need to adopt approved EHR systems by a specified date
and to use them properly in providing clinical care.
EHR system regulation would require the formulation of an enabling statute,373 and the enabling statute or the implementing regulations would need to include both civil and criminal penalties.374 The
regulatory agency should also be empowered to investigate complaints of non-compliance and to initiate compliance reviews on its
own,375 just as HHS and CMS may investigate covered entities that
are suspected of failing to comply with the HIPAA Privacy Rule.376 If
CMS becomes the regulatory agency, the statute and regulations could
also provide that noncompliant health care providers will be denied
payment for services covered by Medicare, Medicaid, and SCHIP.377
The Joint Commission, formerly the Joint Commission on Accreditation of Healthcare Organizations,378 could also contribute to
enforcement efforts. The Joint Commission is a not-for-profit organization that accredits almost 15,000 U.S. health care organizations and
programs according to standards that it develops.379 Once EHR system adoption becomes mandatory, the Joint Commission could add
standards related to EHR systems to its accreditation criteria380 in order to monitor entities’ adoption and effective use of these mechanisms.

372. See supra Part IV.B.
373. Regulatory authority could be included in new legislation or as an amendment to existing legislation, such as HIPAA or the Public Health Service Act. See S. 1693, 110th
Cong. (2007) (proposing to amend the Public Health Services Act to add HIT provisions).
374. The penalty system could be based on the system that has already been established
for HIPAA Privacy Rule violations. See 42 U.S.C. §§ 1320d-5 to 1320d-6 (2000); 45 C.F.R.
§§ 160.400–.426 (2007) (establishing civil penalties for violations of the HIPAA Privacy
Rule).
375. See 45 C.F.R. §§ 160.306, .308 (2007) (setting out the enforcement model established by the HIPAA Privacy Rule).
376. Id.; see, e.g., Jaikumar Vijayan, HIPAA Audit Riles Health IT: Medical Industry on
Edge After Feds Examine Hospital’s Security Procedures, COMPUTERWORLD, June 18,
2007, at 1, 1 (reporting that HHS initiated a HIPAA Security Rule audit of Piedmont Hospital in Atlanta in March 2007).
377. See 42 U.S.C. § 1395i-3(h)(2)(B)(i) (2000) (authorizing the HHS Secretary to deny
payment to skilled nursing facilities that have not met particular requirements); 42 C.F.R.
§ 488.417 (2007) (providing that noncompliant long term care facilities may be denied
Medicare and Medicaid payments for new admissions).
378. The
Joint
Commission
Launches
New
Brand
Identity,
http://www.jointcommission.org/AboutUs/brand.htm (last visited Dec. 19, 2008).
379. Facts about the Joint Commission, http://www.jointcommission.org/AboutUs/
Fact_Sheets/joint_commission_facts.htm (last visited Dec. 19, 2008).
380. See Standards Frequently Asked Questions, http://www.jointcommission.org/
Standards/FAQs/ (last visited Dec. 19, 2008) (elaborating the Joint Commission’s current
standards).
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Furthermore, the threat of product liability or medical malpractice
litigation could deter misconduct by both EHR system vendors and
health care providers. Plaintiffs may sue providers if they suspect that
they suffered poor outcomes because providers failed to implement or
properly use EHR systems, for example, by neglecting to utilize decision-support features that may have averted a medical mistake. Likewise, plaintiffs might name EHR system vendors as defendants if they
believe the harm is rooted at least partly in a design flaw, and health
care providers might bring in vendors as third party defendants if they
believe the vendors to be partially at fault.381 Audit logs and capture/replay382 would be helpful to all parties in investigating and proving their claims concerning system failures and provider negligence or
lack thereof.
HHS has been accused of providing only anemic enforcement for
the HIPAA Privacy Rule and HIPAA Security Rule.383 Whatever
agency is charged with regulating EHR systems will need sufficient
funding to engage in robust enforcement activities. However, because
plaintiffs can already sue both health care providers and EHR system
vendors through the tort system, the statute need not offer a private
cause of action to aggrieved individuals. In 2008, the Supreme Court
held that federal legislation pre-empts common law claims that challenge the safety or efficacy of medical devices that have received
FDA premarket approval.384 Because software defects can manifest
for the first time long after EHR systems are initially approved,385
similar preemption of common law claims would be inappropriate for
these systems.

381. See FED. R. CIV. P. 14 (discussing third-party practice). At the same time, EHR system failures might be very difficult to prove because of the products’ complexities, and thus
the threat of litigation alone might be of somewhat limited value as a deterrent to malfeasance by vendors. See supra note 177 and accompanying text.
382. See supra Part IV.C.3.
383. See Hoffman & Podgurski, supra note 121, at 356–57 (discussing HHS enforcement
activities); see also OFFICE OF INSPECTOR GEN., U.S. DEP’T OF HEALTH & HUMAN SERVS.,
NATIONWIDE REVIEW OF THE CENTERS FOR MEDICARE & MEDICAID SERVICES HEALTH
INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 OVERSIGHT i–ii (2008),
available at http://oig.hhs.gov/oas/reports/region4/40705064.pdf (finding that “CMS relied
on complaints to identify any noncompliant covered entities that it might investigate. As a
result, CMS had no effective mechanism to ensure that covered entities were complying
with the HIPAA Security Rule or that [electronic protected health information] was being
adequately protected.”); Baldas, supra note 125, at 4 (stating that, according to some lawyers, “the government is finally putting teeth into a law that has yielded more than 26,000
complaints, but only four convictions”).
384. Riegel v. Medtronic, Inc., 128 S.Ct. 999, 1007–11 (2008). Under Riegel, common
law claims involving products approved through the 510(k) process are not preempted. Id. at
1007.
385. See supra notes 194–95 and accompanying text.
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D. Improving Health Care Through EHR-based Research
Commentators have noted that the contemporary medical world is
characterized by a startling degree of uncertainty.386 According to
some estimates, as few as twenty to twenty-five percent of treatments
have been definitively proven effective.387 EHR systems could contribute significantly to the advancement of medical knowledge by facilitating extensive research initiatives.388
The federal regulations could provide for the creation of a vast
database consisting of de-identified patient records from hospitals,
providers of ambulatory care, long term health care facilities, and all
other health care settings. Providers would be required to upload records onto the site on a periodic basis, and the database would be
overseen and operated by the designated regulatory agency.
Electronic records can be “sanitized” automatically to remove
identifying information,389 but the federal regulations would need to
define what constitutes sufficient de-identification.390 In doing so,
they would seek to ensure that data mining techniques cannot be used
to infer patient identities from a combination of sanitized records and

386. See, e.g., CROSSING THE QUALITY CHASM, supra note 68, at 145 (asserting that it
takes 15 to 20 years to translate the discovery of a more efficacious treatment into “routine
patient care” and that “adherence of clinical practice to the evidence is highly uneven”);
David A. Hyman & Charles Silver, The Poor State of Health Care Quality in the U.S.: Is
Malpractice Liability Part of the Problem or Part of the Solution?, 90 CORNELL L. REV.
893, 952 (2005) (observing that a “great deal of uncertainty exists about the ‘best’ treatment
for particular clinical conditions, and about the ‘best’ way to perform those treatments” and
that the “efficacy of most medical treatments has never been proven”); see also Blue Cross
Health Plans Recommend Institute to Study Treatments’ Effectiveness, 6 MED. RESEARCH L.
& POL’Y 278, 278 (2007) (reporting that Blue Cross urged Congress “to establish an independent public/private institute to fund research on the comparative effectiveness of various
medical treatments, medications, and medical devices”).
387. John Carey, Medical Guesswork: From Heart Surgery to Prostate Cancer, the
Health Industry Knows Little About Which Common Treatments Really Work,
BUSINESSWEEK, May 29, 2006, at 72, 72 (asserting that many physicians “say the portion of
medicine that has been proven effective is still outrageously low — in the range of 20% to
25%”).
388. Kevin M. Fickenscher, The New Frontier of Data Mining, HEALTH MGMT. TECH.,
Oct. 2005, at 26, 26, available at http://archive.healthmgttech.com/cgi-bin/arttop.asp?
Page=1005/1005new_frontier.htm (“With the advent of the electronic health record, new
opportunities for uncovering patterns of care we did not know existed will come to the
forefront of medical knowledge.”).
389. Matt Bishop et al., How to Sanitize Data, 2004 PROC. 13TH IEEE INT’L
WORKSHOPS ON ENABLING TECHS.: INFRASTRUCTURE FOR COLLABORATIVE ENTERS. 217,
217, available at http://nob.cs.ucdavis.edu/~bishop/papers/2004-wetice/basicsani.pdf (explaining that when sanitization is implemented, “the raw data is presented for others to
analyze, but the data is transformed so that sensitive items are suppressed,” as is the case
when researchers are given patient records from which identifying information, such as
name, address, and phone number are expunged).
390. 45 C.F.R. § 164.514(a)–(b) (2007) (stating the HIPAA Privacy Rule’s specifications
of what constitutes de-identified data).
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other available data.391 Although patients should not be allowed to opt
out of inclusion in EHR systems and the NHIN,392 they should be
provided a choice concerning inclusion in the research database. Patients would be asked to sign a consent form at the time of their initial
visit to a provider or admission to a health care facility indicating their
agreement or refusal to have their de-identified EHRs entered into the
national research database.393 With sufficient reassurance that records
will in fact be de-identified and that their confidentiality will be protected, many patients may consent to inclusion of their records in the
database.
Research using this information could be conducted with few
regulatory burdens. De-identified records do not require IRB review
and are not subject to coverage by the HIPAA Privacy Rule.394 The
databank would be accessible to qualified researchers who register
with the regulatory agency and meet its criteria for approval. Agency
review committees could scrutinize applications, and the agency could
require applicants to prove their identities and affiliations and to provide a limited description of the planned research projects, along with
other relevant information. Access to the databank would be granted
for a period limited to the duration of the study.
The scientific community is already familiar with the Coriell Institute for Medical Research, which maintains one of the world’s largest repositories of human cells.395 The institute has distributed over
160,000 cell lines and over 50,000 DNA samples a year to researchers
in sixty-two countries.396 The proposed databank would constitute a
similar resource, containing health records rather than biological samples.

391. Vassilios S. Verykios et al., State-of-the-Art in Privacy Preserving Data Mining,
33 SIGMOD REC. 50, 50–57 (2004), available at http://www.sigmod.org/record/
issues/0403/B1.bertion-sigmod-record2.pdf (“[S]ensitive knowledge which can be mined
from a database by using data mining algorithms, should also be excluded, because such a
knowledge can equally well compromise data privacy.”).
392. See supra text accompanying note 350.
393. Patients should also be able to withdraw consent to having new information submitted to the databank. However, it might not be at all feasible to expunge existing medical
records concerning a particular patient, because they may be in use by various researchers.
394. The federal regulations that require IRB review cover only research on human subjects and define “human subject” as “a living individual about whom an investigator . . .
obtains (1) data through intervention or interaction with the individual, or (2) identifiable
private information.” 45 C.F.R. § 46.102 (2007); see also 45 C.F.R. § 46.101(b)(4) (2007)
(exempting research “involving the collection or study of existing data, documents, [or]
records . . . if the information is recorded by the investigator in such a manner that subjects
cannot be identified, directly or through identifiers linked to the subjects”). Likewise, the
HIPAA Privacy Rule covers only “individually identifiable health information.” See
45 C.F.R. § 160.103 (2007) (defining “protected health information”).
395. See Coriell Institute for Medical Research — About Coriell, http://www.coriell.org/
index.php/content/view/110/234/ (last visited Dec. 19, 2008).
396. Id.
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The databank would enable researchers to conduct comprehensive, non-experimental studies based on the actual clinical experience
of patients and care givers.397 The importance of such research capabilities has already been recognized by the federal government. In
2007, Congress authorized the FDA to oversee the creation of a national data network, the Sentinel System. This project aims ultimately
to make the data of 100 million Americans available for purposes of
post-marketing drug surveillance and safety analysis. The data will be
drawn from records from Medicare, the military, private insurance
claims, pharmaceutical purchases, and elsewhere.398
The research databank proposed in this Article would go much
further than this initiative. It could potentially include the records of
all Americans, be accessible to government and to private researchers,
and be used to study all treatments rather than focusing only on those
involving pharmaceutical products. Once created, this databank could
replace all smaller-scale data collections.
While research derived from the proposed national databank
would not be a substitute for clinical trials, it would constitute an invaluable supplement to them. Researchers would be able to verify the
success or failure of treatment protocols as they are applied to different patient populations, based on review of millions of patient files
covering many years.

V. CONCLUSION
EHR systems offer great promise for significantly improving
health care in the U.S. and around the world. The technology could
address many of the health care system’s shortcomings and have farreaching positive impacts on patient welfare. For example, HIT could
do all of the following: decrease medical errors; enhance preventive
care; facilitate communication between doctors and patients and
among medical team members; reduce health disparities; and advance
biomedical research capabilities.399
The complexity of EHR systems, however, generates many risks
of software and hardware failures and adverse patient outcomes. Consequently, they require rigorous regulation. Some risks can stem from
system defects and others from usability problems. Advanced EHR
systems that will be developed in the future could improve health out-

397. See supra notes 84–100 and accompanying text (comparing experimental and nonexperimental studies).
398. See 21 U.S.C.A. § 355(k) (West 1999 & Supp. 2008); Barbara J. Evans, Congress’
New Infrastructural Model of Medical Privacy, 84 NOTRE DAME L. REV. (forthcoming Feb.
2009) (manuscript at 2–4), available at http://papers.ssrn.com/sol3/papers.cfm?
abstract_id=1186462.
399. See supra Part II.B (detailing the benefits of EHR systems).
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comes to an even greater extent, but they may also pose more serious
risks because of increased complexity.
Although EHR system regulation is needed, it is a challenging
and sensitive undertaking. A tension exists between the goals of regulating EHR systems comprehensively and facilitating their widespread
and imminent adoption. The more extensive and burdensome the regulations, the more providers will resist purchasing EHR systems. We
have attempted to craft a balanced approach that provides incentives
for EHR system development and adoption while safeguarding patient
welfare and deterring misconduct on the part of the software and
health care industries. As laws and regulations are promulgated in this
area, policy makers will need to continue to consider carefully the
competing goals and to balance oversight with promotion of HIT.
Innumerable details and requirements could be included in the
federal regulations. We have not offered comprehensive suggestions
or specific regulatory language. Rather, we outlined a regulatory
framework and focused on what we believe to be some of the essential issues in the realm of EHR system oversight. The task of EHR
system regulation, however, must commence at the earliest opportunity. It is only with appropriate statutory and regulatory interventions
that the full benefits of this potentially transformative medical technology can be realized.

